P059 Long-term results of CHOP/CHOP like chemotherapy +- rituximab in patients with diffuse large B-cell lymphoma (DLBCL) (English)
- New search for: Mihaljevic, B.
- New search for: Sretenovic, S.
- New search for: Jankovic, S.
- New search for: Andjelic, B.
- New search for: Jakovic, L.
- New search for: Milicic, B.
- New search for: Bila, J.
- New search for: Milosevic, V.
- New search for: Sretenovic, A.
- New search for: Perunicic, M.
- New search for: Mihaljevic, B.
- New search for: Sretenovic, S.
- New search for: Jankovic, S.
- New search for: Andjelic, B.
- New search for: Jakovic, L.
- New search for: Milicic, B.
- New search for: Bila, J.
- New search for: Milosevic, V.
- New search for: Sretenovic, A.
- New search for: Perunicic, M.
In:
LEUKEMIA RESEARCH -OXFORD-
;
31
;
S91
;
2007
-
ISSN:
- Article (Journal) / Print
-
Title:P059 Long-term results of CHOP/CHOP like chemotherapy +- rituximab in patients with diffuse large B-cell lymphoma (DLBCL)
-
Contributors:Mihaljevic, B. ( author ) / Sretenovic, S. ( author ) / Jankovic, S. ( author ) / Andjelic, B. ( author ) / Jakovic, L. ( author ) / Milicic, B. ( author ) / Bila, J. ( author ) / Milosevic, V. ( author ) / Sretenovic, A. ( author ) / Perunicic, M. ( author )
-
Published in:LEUKEMIA RESEARCH -OXFORD- ; 31 ; S91
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam.
-
Publication date:2007-01-01
-
Size:S91
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.99419
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.99419 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 31
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
Cancer testis/germline antigens (CT/CG-antigens) in leukemiasGreiner, J. / Schmitt, M. et al. | 2007
- 5
-
Acute promyelocytic leukemia-mobile and infiltrativeLiesveld, J. L. et al. | 2007
- 9
-
Atiprimod: A multi-functional drug candidate for myeloid and other malignanciesShailubhai, K. et al. | 2007
- 11
-
The Third International Congress on Myeloproliferative and Myelodysplastic SyndromesSilver, R. T. / Bennett, J. M. / Goldman, J. M. / Spivak, J. L. / Tefferi, A. et al. | 2007
- 19
-
Clinical response of myelodysplastic syndromes patients to treatment with coenzyme Q10Galili, N. / Sechman, E. V. / Cerny, J. / Mehdi, M. / Mumtaz, M. / Westervelt, P. / Maguire, J. / Raza, A. et al. | 2007
- 27
-
Rare mutations of the PIK3CA gene in malignancies of the hematopoietic system as well as endometrium, ovary, prostate and osteosarcomas, and discovery of a PIK3CA pseudogeneMuller, C. I. / Miller, C. W. / Hofmann, W. K. / Gross, M. E. / Walsh, C. S. / Kawamata, N. / Luong, Q. T. / Koeffler, H. P. et al. | 2007
- 33
-
mRNA expression of MAGE-A3 gene in leukemia cellsMartinez, A. / Olarte, I. / Mergold, M. A. / Gutierrez, M. / Rozen, E. / Collazo, J. / Amancio-Chassin, O. / Ordonez, R. M. / Montesinos, J. J. / Mayani, H. et al. | 2007
- 39
-
Analysis of complex chromosomal rearrangements in adult patients with MDS and AML by multicolor FISHBabicka, L. / Ransdorfova, S. / Brezinova, J. / Zemanova, Z. / Sindelarova, L. / Siskova, M. / Maaloufova, J. / Cermak, J. / Michalova, K. et al. | 2007
- 49
-
b2 Integrins are characteristically absent in acute promyelocytic leukemia and rapidly upregulated in vivo upon differentiation with all-trans retinoic acidWu, J. J. / Cantor, A. / Moscinski, L. C. et al. | 2007
- 59
-
The spectrum of myelodysplastic syndromes post-solid organ transplantation: A single institutional experienceMenes, M. / Vakiani, E. / Keller, C. E. / Ho, E. K. / Colovai, A. / Nichols, G. / Diuguid, D. / Mears, J. G. / Murty, V. V. / Alobeid, B. et al. | 2007
- 67
-
Trisomy 8 as sole anomaly or with other clonal aberrations in acute myeloid leukemia: Impact on clinical presentation and outcomeJaff, N. / Chelghoum, Y. / Elhamri, M. / Tigaud, I. / Michallet, M. / Thomas, X. et al. | 2007
- 75
-
Molecular response of leukemia HL-60 cells to genistein treatment, a proteomics studyZhang, D. / Tai, Y. C. / Wong, C. H. / Tai, L. K. / Koay, E. S. / Chen, C. S. et al. | 2007
- 83
-
In vitro functional alterations in the hematopoietic system of adult patients with acute lymphoblastic leukemiaMartinez-Jaramillo, G. / Vela-Ojeda, J. / Sanchez-Valle, E. / Montesinos, J. J. / Mayani, H. et al. | 2007
- 91
-
Atiprimod blocks phosphorylation of JAK-STAT and inhibits proliferation of acute myeloid leukemia (AML) cellsFaderl, S. / Ferrajoli, A. / Harris, D. / Van, Q. / Kantarjian, H. M. / Estrov, Z. et al. | 2007
- 97
-
Usefulness of JAK2V617F mutation in distinguishing idiopathic erythrocytosis from polycythemia veraRossi, D. / Cortini, F. / Deambrogi, C. / Barbieri, C. / Cerri, M. / Franceschetti, S. / Conconi, A. / Capello, D. / Gaidano, G. et al. | 2007
- 103
-
Differences in epidemiology of MDS between Western and Eastern countries: Ethnic differences or environmental influence?Kuendgen, A. / Matsuda, A. / Germing, U. et al. | 2007
- 105
-
Solid tumors subsequent to arsenic trioxide treatment for acute promyelocytic leukemiaAu, W. Y. / Kumana, C. R. / Lam, C. W. / Cheng, V. C. / Shek, T. W. / Chan, E. Y. / Liu, R. / Kwong, Y. L. et al. | 2007
- 109
-
NPM1 mutations in myelodysplastic syndromes and acute myeloid leukemia with normal karyotypeZhang, Y. / Zhang, M. / Yang, L. / Xiao, Z. et al. | 2007
- 113
-
Immunophenotyping of surface antigens in acute myeloid leukemia by flow cytometry after red blood cell lysisSchwonzen, M. / Diehl, V. / Dellanna, M. / Staib, P. et al. | 2007
- 117
-
Cytomegalovirus-associated hemophagocytic syndrome with clonal cytogenetic abnormalities in an elderly maleNishida, H. / Ogura, Y. / Yoshimizu, N. / Ueno, H. / Park, J. W. / Yano, T. / Ikeda, Y. et al. | 2007
- 119
-
Cryptococcus lung infection complicating fludarabine treatment in a chronic lymphocytic leukemia patientBenetatos, L. / Hatzimichael, E. / Vassou, A. / Bourantas, K. L. et al. | 2007
- 121
-
Soluble HLA revisitedTabayoyong, W. B. / Zavazava, N. et al. | 2007
- 127
-
Advances in AML immunotherapy: The case for T-bodiesSuh, D. Y. / Frankel, A. E. et al. | 2007
- 129
-
Myeloma bone disease: Pathogenetic mechanisms and clinical assessmentSilvestris, F. / Lombardi, L. / De Matteo, M. / Bruno, A. / Dammacco, F. et al. | 2007
- 139
-
Clinical relevance of soluble HLA-I and b2-microglobulin levels in non-Hodgkins lymphoma and Hodgkins diseaseAlbitar, M. / Vose, J. M. / Johnson, M. M. / Do, K. A. / Day, A. / Jilani, I. / Kantarjian, H. / Keating, M. / O'Brien, S. M. / Verstovsek, S. et al. | 2007
- 147
-
Detection of hematopoietic maturation abnormalities by flow cytometry in myelodysplastic syndromes and its utility for the differential diagnosis with non-clonal disordersLorand-Metze, I. / Ribeiro, E. / Lima, C. S. / Batista, L. S. / Metze, K. et al. | 2007
- 157
-
CD7 expression predicts poor disease free survival and post-remission survival in patients with acute myeloid leukemia and normal karyotypeChang, H. / Yeung, J. / Brandwein, J. / Yi, Q. l. et al. | 2007
- 163
-
Coding sequence and intron-exon junctions of the c-myb gene are intact in the chronic phase and blast crisis stages of chronic myeloid leukemia patientsBussolari, R. / Candini, O. / Colomer, D. / Corradini, F. / Guerzoni, C. / Mariani, S. A. / Cattelani, S. / Silvestri, C. / Pecorari, L. / Iacobucci, I. et al. | 2007
- 169
-
RAD51 homologous recombination repair gene haplotypes and risk of acute myeloid leukaemiaRollinson, S. / Smith, A. G. / Allan, J. M. / Adamson, P. J. / Scott, K. / Skibola, C. F. / Smith, M. T. / Morgan, G. J. et al. | 2007
- 175
-
Aberrant methylation in pediatric myelodysplastic syndromeVidal, D. O. / Paixao, V. A. / Brait, M. / Souto, E. X. / Caballero, O. L. / Lopes, L. F. / Vettore, A. L. et al. | 2007
- 183
-
CD5 provides viability signals to B cells from a subset of B-CLL patients by a mechanism that involves PKCPerez-Chacon, G. / Vargas, J. A. / Jorda, J. / Morado, M. / Rosado, S. / Martin-Donaire, T. / Losada-Fernandez, I. / Rebolleda, N. / Perez-Aciego, P. et al. | 2007
- 195
-
In vitro generation of tumor specific T cells that recognize a shared antigen of AML: Molecular characterization of TCR genesCoppage, M. / Belanger, T. / Zauderer, M. / Sahasrabudhe, D. et al. | 2007
- 203
-
Identification of a constitutively active mutant of JAK3 by retroviral expression screeningChoi, Y. L. / Kaneda, R. / Wada, T. / Fujiwara, S. i. / Soda, M. / Watanabe, H. / Kurashina, K. / Hatanaka, H. / Enomoto, M. / Takada, S. et al. | 2007
- 211
-
Analysis of the CD33-related siglec family reveals that Siglec-9 is an endocytic receptor expressed on subsets of acute myeloid leukemia cells and absent from normal hematopoietic progenitorsBiedermann, B. / Gil, D. / Bowen, D. T. / Crocker, P. R. et al. | 2007
- 221
-
A proteomic analysis of protein variations during differentiation of v-myb-transformed monoblastsOndrouskova, E. / Povolna, K. / Vana, P. / Benes, P. / Konecna, H. / Zdrahal, Z. / Smarda, J. et al. | 2007
- 231
-
VH3-48 and VH3-53, as well as VH3-21, gene rearrangements define unique subgroups in CLL and are associated with biased lambda light chain restriction, homologous LCDR3 sequences and poor prognosisMatthews, C. / Catherwood, M. A. / Morris, T. C. / Alexander, H. D. et al. | 2007
- 235
-
Clonal evolution of 8p11 stem cell syndrome in a 14-year-old Chinese boy: A review of literature of t(8;13) associated myeloproliferative diseasesWong, W. S. / Cheng, K. C. / Lau, K. M. / Chan, N. P. / Shing, M. M. / Cheng, S. H. / Chik, K. W. / Li, C. K. / Ng, M. H. et al. | 2007
- 239
-
Identification of PML-RARA rearrangement by RT-PCR and sequencing in an acute promyelocytic leukemia without t(15;17) on G-banding and FISHHan, J. Y. / Kim, K. E. / Kim, K. H. / Park, J. I. / Kim, J. S. et al. | 2007
- 245
-
Chronic lymphocytic leukemia patients with a V1-69 gene rearrangement do not have inferior survival with respect to patients that express other unmutated VH genesPanovska-Stavridis, I. / Ivanovski, M. / Siljanovski, N. / Cevreska, L. / Efremov, D. G. et al. | 2007
- 249
-
A mathematical model for the evaluation of amplitude of hemoglobin fluctuations in elderly anemic patients affected by myelodysplastic syndromes: correlation with quality of life and fatigueCaocci, G. / Baccoli, R. / Ledda, A. / Littera, R. / La Nasa, G. et al. | 2007
- 253
-
Low-dose thalidomide in combination with oral fludarabine and cyclophosphamide is ineffective in heavily pre-treated patients with chronic lymphocytic leukemiaLaurenti, L. / Piccioni, P. / Tarnani, M. / De Padua, L. / Garzia, M. / Efremov, D. G. / Piccirillo, N. / Chiusolo, P. / Sica, S. / Leone, G. et al. | 2007
- 257
-
Successful treatment of relapsed AML after allogeneic stem cell transplantation with azacitidineGraef, T. / Kuendgen, A. / Fenk, R. / Zohren, F. / Haas, R. / Kobbe, G. et al. | 2007
- 261
-
Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic clonePullarkat, V. / Bedell, V. / Kim, Y. / Bhatia, R. / Nakamura, R. / Forman, S. / Sun, J. / Senitzer, D. / Slovak, M. L. et al. | 2007
- 267
-
Fludarabine-induced autoimmune hemolytic anemia in a CLL patient: Rituximab as the treatment of choice?Smolej, L. et al. | 2007
- 268
-
Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemiaNishida, H. / Murase, T. / Ueno, H. / Park, J. W. / Yano, T. / Ikeda, Y. et al. | 2007
- 269
-
May the correlation between Kit-D816 mutation and AML1-ETO level change the use of prognostic factors in t(8;21) AML?Potenza, L. / Luppi, M. / Riva, G. / Ottaviani, E. / Zucchini, P. / Morselli, M. / Volzone, F. / Forghieri, F. / Martinelli, G. / Torelli, G. et al. | 2007
- 273
-
Is "leukemia" an appropriate label for all patients who meet the diagnostic criteria of chronic lymphocytic leukemia?Victor Hoffbrand, A. / Hamblin, T. J. et al. | 2007
- 277
-
Larger than life: Mitochondria and the Bcl-2 familySkommer, J. / Wlodkowic, D. / Deptala, A. et al. | 2007
- 287
-
Is intestinal diffuse large b cell lymphoma a relatively benign disease?Daum, S. / Thiel, E. / Zeitz, M. et al. | 2007
- 291
-
New chemical strategies for overcoming ATRA resistance in APL cellsCoradini, D. et al. | 2007
- 293
-
Molecular basis for decreased folylpoly-g-glutamate synthetase expression in a methotrexate resistant CCRF-CEM mutant cell lineLeclerc, G. J. / York, T. A. / Hsieh-Kinser, T. / Barredo, J. C. et al. | 2007
- 301
-
Designed ATRA analogue active against ATRA-resistant acute promyelocytic leukemia cells having a single nucleotide substitution in their retinoic acid receptorKomura, N. / Ikeda, Y. / Masuda, N. / Umezawa, Y. / Ito, K. / Kizaki, M. / Umezawa, K. et al. | 2007
- 315
-
Constitutive CD40 signaling phenocopies the transforming function of the Epstein-Barr virus oncoprotein LMP1 in vitroHatzivassiliou, E. G. / Kieff, E. / Mosialos, G. et al. | 2007
- 321
-
Activating Notch1 mutations are an early event in T-cell malignancy of Ikaros point mutant Plastic/+ miceMantha, S. / Ward, M. / McCafferty, J. / Herron, A. / Palomero, T. / Ferrando, A. / Bank, A. / Richardson, C. et al. | 2007
- 329
-
Arsenic trioxide induces not only apoptosis but also autophagic cell death in leukemia cell lines via up-regulation of Beclin-1Qian, W. / Liu, J. / Jin, J. / Ni, W. / Xu, W. et al. | 2007
- 341
-
Inhibitors of the mevalonate pathway as potential therapeutic agents in multiple myelomaBaulch-Brown, C. / Molloy, T. J. / Yeh, S. L. / Ma, D. / Spencer, A. et al. | 2007
- 353
-
Predisposition to therapy-related acute leukemia with balanced chromosomal translocations does not result from a major constitutive defect in DNA double-strand break end joiningCoiteux, V. / Onclercq-Delic, R. / Fenaux, P. / Amor-Gueret, M. et al. | 2007
- 359
-
Prospective clinical study of surgical resection followed by CHOP in localized intestinal diffuse large B cell lymphomaLee, J. / Kim, W. S. / Kim, K. / Ahn, J. S. / Jung, C. W. / Lim, H. Y. / Kang, W. K. / Park, K. / Ko, Y. H. / Kim, Y. H. et al. | 2007
- 365
-
PRAME mRNA levels in cases with chronic leukemia: Clinical importance and review of the literaturePaydas, S. / Tanriverdi, K. / Yavuz, S. / Seydaoglu, G. et al. | 2007
- 371
-
T-cell type lymphoproliferative disease of granular lymphocytes (LDGL) is equipped with a phenotypic pattern typical of effector cytotoxic cellsBaesso, I. / Pavan, L. / Boscaro, E. / Miorin, M. / Facco, M. / Trentin, L. / Agostini, C. / Zambello, R. / Semenzato, G. et al. | 2007
- 379
-
Alcohol consumption and risk of leukemia: A multicenter case-control studyGorini, G. / Stagnaro, E. / Fontana, V. / Miligi, L. / Ramazzotti, V. / Nanni, O. / Rodella, S. / Tumino, R. / Crosignani, P. / Vindigni, C. et al. | 2007
- 387
-
The changes of oxidative stress and human 8-hydroxyguanine glycosylase1 gene expression in depressive patients with acute leukemiaZhou, F. / Zhang, W. / Wei, Y. / Zhou, D. / Su, Z. / Meng, X. / Hui, L. / Tian, W. et al. | 2007
- 395
-
In vitro leukemic cell differentiation and WT1 gene expressionHernandez-Caballero, E. / Mayani, H. / Montesinos, J. J. / Arenas, D. / Salamanca, F. / Penaloza, R. et al. | 2007
- 399
-
Functional platelet-activating factor receptors in immature forms of leukemic blastsReynaud, S. / Malissein, E. / Donnard, M. / Bordessoule, D. / Turlure, P. / Trimoreau, F. / Denizot, Y. et al. | 2007
- 403
-
Production of vascular endothelial growth factor in T-cell prolymphocytic leukemiaOgasawara, T. / Narita, C. / Kawauchi, K. et al. | 2007
- 407
-
Induction of complete remission in a patient with acute myeloid leukemia refractory to high-dose chemotherapy through treatment with 5-azacytidineKuendgen, A. / Graf, T. / Zohren, F. / Hildebrandt, B. / Hunerliturkoglu, A. / Gattermann, N. / Haas, R. / Kobbe, G. et al. | 2007
- 412
-
Open forum-Are myelodysplastic syndromes cancer?:Response to Dr. SteensmaHamblin, T. et al. | 2007
- 413
-
Long-lasting response of therapy-resistant viral warts to treatment with interleukin-2 in a patient with chronic lymphocytic leukemia (CLL) and profound immunodeficiencyHamblin, T. J. et al. | 2007
- 414
-
Late onset aplastic anemia during treatment of chronic myeloid leukemia with imatinib mesylateLeMarbre, G. / Schinstock, C. / Hoyer, R. / Krook, J. / Tefferi, A. et al. | 2007
- 416
-
Ultra high platelet count might be a characteristic feature of chronic myeloid leukemia rather than essential thrombocythemiaTefferi, A. et al. | 2007
- 417
-
Ph-positive acute lymphoblastic leukemia after long-term remission of Ph-positive acute myeloid leukemiaNishida, H. / Yoshimizu, N. / Ueno, H. / Fujita, A. / Kato, T. / Park, J. W. / Yano, T. / Tobinai, K. / Ikeda, Y. et al. | 2007
- 418
-
Infliximab in chronic myelogenous leukemiaMittre, H. / Marcelli, C. / Leporrier, M. et al. | 2007
- 421
-
RNAi and tumor angiogenesis: Bridging the gap towards anti-cancer therapy?Dave, R. S. et al. | 2007
- 423
-
Retinoic acid therapy served by ligands cross linking and masking CD38Yen, A. et al. | 2007
- 427
-
Evaluation of recurring cytogenetic abnormalities in the treatment of myelodysplastic syndromesOlney, H. J. / Le Beau, M. M. et al. | 2007
- 435
-
The fundamental contribution of Jan C. Waldenstrom to the discovery and study of the so-called "Waldenstrom macroglobulinemia"Ribatti, D. et al. | 2007
- 439
-
The discovery of endothelial progenitor cells:An historical reviewRibatti, D. et al. | 2007
- 445
-
Contrasting features of MDR phenotype in leukemias by using two fluorochromes: Implications for clinical practiceVasconcelos, F. C. / Cavalcanti, G. B. / Silva, K. L. / de Meis, E. / Kwee, J. K. / Rumjanek, V. M. / Maia, R. C. et al. | 2007
- 455
-
Retinoic acid-induced CD38 antigen promotes leukemia cells attachment and interferon-g/interleukin-1b-dependent apoptosis of endothelial cells: Implications in the etiology of retinoic acid syndromeGao, Y. / Camacho, L. H. / Mehta, K. et al. | 2007
- 465
-
Multidrug resistance protein expression of adult T-cell leukemia/lymphomaYasunami, T. / Wang, Y. h. / Tsuji, K. / Takanashi, M. / Yamada, Y. / Motoji, T. et al. | 2007
- 471
-
Detection of the CBFB/MYH11 fusion gene in de novo acute myeloid leukemia (AML): A single-institution study of 224 Japanese AML patientsMonma, F. / Nishii, K. / Shiga, J. / Sugahara, H. / Lorenzo, F. / Watanabe, Y. / Kawakami, K. / Hosokai, N. / Yamamori, S. / Katayama, N. et al. | 2007
- 477
-
HIC gene, a candidate suppressor gene within a minimal region of loss at 7q31.1 in myeloid neoplasmsCigognini, D. / Corneo, G. / Fermo, E. / Zanella, A. / Tripputi, P. et al. | 2007
- 483
-
The effect of total-ABL, GUS and B2M control genes on BCR-ABL monitoring by real-time RT-PCRRulcova, J. / Zmekova, V. / Zemanova, Z. / Klamova, H. / Moravcova, J. et al. | 2007
- 493
-
Unexpected protection from infection by two booster hepatitis B virus vaccination in children with acute lymphoblastic leukemiaYetgin, S. / Tavil, B. / Aytac, S. / Kuskonmaz, B. / Karna, G. et al. | 2007
- 497
-
Reversal of p15/INK4b hypermethylation in AML1/ETO-positive and -negative myeloid leukemia cell linesBerg, T. / Guo, Y. / Abdelkarim, M. / Fliegauf, M. / Lubbert, M. et al. | 2007
- 507
-
Reduction of intracellular pH inhibits the expression of VEGF in K562 cells after targeted inhibition of the Na+/H+ exchangerHe, B. / Deng, C. / Zhang, M. / Zou, D. / Xu, M. et al. | 2007
- 515
-
Vector-based RNAi approach to isoform-specific downregulation of vascular endothelial growth factor (VEGF)165 expression in human leukemia cellsShen, H. L. / Xu, W. / Wu, Z. Y. / Zhou, L. L. / Qin, R. J. / Tang, H. R. et al. | 2007
- 523
-
Scutellaria baicalensis, a herbal medicine: Anti-proliferative and apoptotic activity against acute lymphocytic leukemia, lymphoma and myeloma cell linesKumagai, T. / Muller, C. I. / Desmond, J. C. / Imai, Y. / Heber, D. / Koeffler, H. P. et al. | 2007
- 531
-
Cytotoxic activity of the third-generation bisphosphonate zoledronic acid in acute myeloid leukemiaFiegl, M. / Juergens, M. / Hiddemann, W. / Braess, J. et al. | 2007
- 541
-
Evidence of LAT as a dual substrate for Lck and Syk in T lymphocytesJiang, Y. / Cheng, H. et al. | 2007
- 547
-
Regular analgesic use and risk of multiple myelomaMoysich, K. B. / Bonner, M. R. / Beehler, G. P. / Marshall, J. R. / Menezes, R. J. / Baker, J. A. / Weiss, J. R. / Chanan-Khan, A. et al. | 2007
- 553
-
Temporary blast reduction after immunoglobulin administration for congenital cytomegalovirus infection masking infant leukemia with cryptic MLL rearrangementMetzler, M. / Bruch, J. / Stachel, D. / Langer, T. / Borkhardt, A. / Harbott, J. / Rascher, W. / Holter, W. et al. | 2007
- 559
-
Bortezomib is an effective agent for MDS/MPD syndrome with 5q- anomaly and thrombocytosisTerpos, E. / Verrou, E. / Banti, A. / Kaloutsi, V. / Lazaridou, A. / Zervas, K. et al. | 2007
- 563
-
Long-term remission in BCR/ABL-positive AML-M6 patient treated with Imatinib MesylatePompetti, F. / Spadano, A. / Sau, A. / Mennucci, A. / Russo, R. / Catinella, V. / Franchi, P. G. / Calabrese, G. / Palka, G. / Fioritoni, G. et al. | 2007
- 569
-
Folate levels and methylation of CDKI proteinsBuda, G. / Maggini, V. / Galimberti, S. / Barale, R. / Rossi, A. M. / Petrini, M. et al. | 2007
- 570
-
Quantitative assessment of WT1 expression in diagnosis of childhood acute leukemiaSpanaki, A. / Linardakis, E. / Perdikogianni, C. / Stiakaki, E. / Morotti, A. / Cilloni, D. / Kalmanti, M. et al. | 2007
- 573
-
Tumour lysis syndrome with acute renal failure during imatinib therapyAli, R. / Ozkalemkas, F. / Ozkan, A. / Ozcelik, T. / Ozkocaman, V. / Akdag, I. / Ozan, U. / Tunali, A. et al. | 2007
- 574
-
Relationship between daily dose of imatinib per square meter and its plasma concentration in patients with chronic-phase chronic myeloid leukemia (CML)Horikoshi, A. / Takei, K. / Sawada, S. et al. | 2007
- 577
-
Abnormal stromal cells in Myelodysplastic Syndromes: Genomics presents further evidenceMayani, H. et al. | 2007
- 579
-
Gene stage-specific expression in the microenvironment of pediatric myelodysplastic syndromesRoela, R. A. / Carraro, D. M. / Brentani, H. P. / Kaiano, J. H. / Simao, D. F. / Guarnieiro, R. / Lopes, L. F. / Borojevic, R. / Brentani, M. M. et al. | 2007
- 591
-
Cytokine and chemokine profiles in multiple myeloma; significance of stromal interaction and correlation of IL-8 production with disease progressionKline, M. / Donovan, K. / Wellik, L. / Lust, C. / Jin, W. / Moon-Tasson, L. / Xiong, Y. / Witzig, T. E. / Kumar, S. / Rajkumar, S. V. et al. | 2007
- 599
-
Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): An overview from the research on adverse drug events and reports (RADAR) projectMcKoy, J. M. / Angelotta, C. / Bennett, C. L. / Tallman, M. S. / Wadleigh, M. / Evens, A. M. / Kuzel, T. M. / Trifilio, S. M. / Raisch, D. W. / Kell, J. et al. | 2007
- 605
-
Utility of interphase FISH to stratify patients into cytogenetic risk categories at diagnosis of AML in an Eastern Cooperative Oncology Group (ECOG) clinical trial (E1900)Vance, G. H. / Kim, H. / Hicks, G. A. / Cherry, A. M. / Higgins, R. / Hulshizer, R. L. / Tallman, M. S. / Fernandez, H. F. / Dewald, G. W. et al. | 2007
- 611
-
Analysis of histone modification around the CpG island region of the p15 gene in acute myeloblastic leukemiaOgawa, M. / Sakashita, K. / Zhao, X. Y. / Hayakawa, A. / Kubota, T. / Koike, K. et al. | 2007
- 623
-
Candidate gene mutation analysis in idiopathic acquired sideroblastic anemia (refractory anemia with ringed sideroblasts)Steensma, D. P. / Hecksel, K. A. / Porcher, J. C. / Lasho, T. L. et al. | 2007
- 629
-
Endostatin variations in childhood acute lymphoblastic leukaemia-Comparison with basic fibroblast growth factor and vascular endothelial growth factorSchneider, P. / Vasse, M. / Corbiere, C. / Legrand, E. / Marie-Cardine, A. / Boquet, C. / Cazin, L. / Vannier, J. P. et al. | 2007
- 639
-
Quantitative assessment of PRAME expression in diagnosis of childhood acute leukemiaSpanaki, A. / Perdikogianni, C. / Linardakis, E. / Kalmanti, M. et al. | 2007
- 643
-
Quantum dot labeling and tracking of human leukemic, bone marrow and cord blood cellsGaron, E. B. / Marcu, L. / Luong, Q. / Tcherniantchouk, O. / Crooks, G. M. / Koeffler, H. P. et al. | 2007
- 653
-
Nitric oxide induces promyelocytic cell growth arrest and apoptosis through deactivation of Akt pathwayWang, X. / Sun, H. / Li, C. et al. | 2007
- 661
-
Expression analysis of PCNA gene in chronic myelogenous leukemia-Combined application of siRNA silencing and expression arraysMerkerova, M. / Bruchova, H. / Brdicka, R. et al. | 2007
- 673
-
Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cellsIkezoe, T. / Nishioka, C. / Bandobashi, K. / Yang, Y. / Kuwayama, Y. / Adachi, Y. / Takeuchi, T. / Koeffler, H. P. / Taguchi, H. et al. | 2007
- 683
-
KN-62 analogues as potent differentiating agents of HL-60 cellsSchuler, A. D. / Si, J. / Mueller, L. / Simon, J. A. / Collins, S. J. et al. | 2007
- 691
-
`Idiopathic' eosinophilia with an Occult T-cell clone: Prevalence and clinical courseVaklavas, C. / Tefferi, A. / Butterfield, J. / Ketterling, R. / Verstovsek, S. / Kantarjian, H. / Pardanani, A. et al. | 2007
- 695
-
Expressions of the VLA-4, LFA-1 and Mac-1 integrins in eosinophil migration in a case of chronic eosinophilic leukaemiaLima, C. S. / Franco-Penteado, C. F. / Canalli, A. A. / Conran, N. / Lorand-Metze, I. / Costa, F. F. / Ferreira, H. H. et al. | 2007
- 699
-
Complex karyotype including chromosomal translocation (8;14) (q24;q32) in one case with B-cell prolymphocytic leukemiaCrisostomo, R. H. / Fernandez, J. A. / Caceres, W. et al. | 2007
- 703
-
Arsenic-induced APL differentiation in cerebrospinal fluidHelwig, A. / Klemm, M. / Schuttig, R. / Rollig, C. / Wassilew, N. / Ehninger, G. / Illmer, T. et al. | 2007
- 707
-
t(8;14)(q24;q32) in two patients with CD10-negative primary thyroid diffuse large B-cell lymphomaNiitsu, N. / Okamoto, M. / Yoshino, T. / Nakamine, H. / Nakamura, N. / Bessho, M. / Hirano, M. / Miura, I. et al. | 2007
- 713
-
Isodicentric Philadelphia chromosome in acute lymphoblastic leukemia with der(7;12)(q10;q10)Yamamoto, K. / Nagata, K. / Morita, Y. / Inagaki, K. / Hamaguchi, H. et al. | 2007
- 719
-
B-CLL cells from lymph nodes express higher ZAP-70 levels than B-CLL cells from peripheral bloodBoelens, J. / Philippe, J. / Offner, F. et al. | 2007
- 720
-
Agent Orange, prostate cancer irradiation and acute promyelocyic leukemia (APL): Is there a link?Atallah, E. / Schiffer, C. A. et al. | 2007
- 721
-
Inefficacy of bortezomib therapy for CNS involvement of refractory multiple myelomaMele, G. / Pinna, S. / Alloro, E. / Brocca, M. C. / Coppi, M. R. / Quarta, G. et al. | 2007
- 723
-
Deletion of chromosome 13: A rare form of cytogenetic evolution in blast phase of chronic myelogenous leukemia:Is there an association with favorable outcome?Callera, F. / Rosa, E. S. / Mulin, C. C. et al. | 2007
- 725
-
Imatinib-induced apoptosis in the eosinophils of patients with a hypereosinophilic syndrome: A surrogate marker of response?Pitini, V. / Arrigo, C. / Altavilla, G. / Naro, C. / Righi, M. et al. | 2007
- 727
-
Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conferenceValent, P. / Horny, H. P. / Bennett, J. M. / Fonatsch, C. / Germing, U. / Greenberg, P. / Haferlach, T. / Haase, D. / Kolb, H. J. / Krieger, O. et al. | 2007
- 737
-
Primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (post-PV MF), post essential thrombocythemia myelofibrosis (post-ET MF), blast phase PMF (PMF-BP): Consensus on terminology by the international working group for myelofibrosis research and treatment (IWG-MRT)Mesa, R. A. / Verstovsek, S. / Cervantes, F. / Barosi, G. / Reilly, J. T. / Dupriez, B. / Levine, R. / Le Bousse-Kerdiles, M. C. / Wadleigh, M. / Campbell, P. J. et al. | 2007
- 741
-
A selective activity of DNMTi decitabine on AML1ETO positive cells?Santini, V. et al. | 2007
- 743
-
Is childhood MDS an epigenetic disease?Flotho, C. et al. | 2007
- 745
-
Hyperbaric oxygen: A potential new therapy for leukemia?Tonomura, N. / Granowitz, E. V. et al. | 2007
- 747
-
Control of hematopoiesis and apoptosis in MDS: More than FLIPing the coinMhyre, A. J. / Deeg, H. J. et al. | 2007
- 751
-
Impact of visceral involvements and blood cell count abnormalities on survival in adult T-cell leukemia/lymphoma (ATLL)Takasaki, Y. / Iwanaga, M. / Tsukasaki, K. / Kusano, M. / Sugahara, K. / Yamada, Y. / Kamihira, S. / Ikeda, S. / Tomonaga, M. et al. | 2007
- 759
-
Genetic variations in benzene metabolism and susceptibility to multiple myelomaLincz, L. F. / Scorgie, F. E. / Robertson, R. / Enno, A. et al. | 2007
- 765
-
A survival study and prognostic factors analysis on acute promyelocytic leukemia at a single centerXin, L. / Wan-jun, S. / Zeng-jun, L. / Yao-zhong, Z. / Yun-tao, L. / Yan, L. / Chang-chun, W. / Qiao-chuan, L. / Ren-chi, Y. / Ming-zhe, H. et al. | 2007
- 773
-
Progressive disease in chronic lymphocytic leukemia is correlated with the DNA methylation indexYu, M. K. / Bergonia, H. / Szabo, A. / Phillips, J. D. et al. | 2007
- 779
-
Bortezomib therapy response is independent of cytogenetic abnormalities in relapsed/refractory multiple myelomaChang, H. / Trieu, Y. / Qi, X. / Xu, W. / Stewart, K. A. / Reece, D. et al. | 2007
- 783
-
Functional variations in the JWA gene are associated with increased odds of leukemiasShen, Q. / Tang, W. Y. / Li, C. P. / Chen, R. / Zhu, Y. J. / Huang, S. / Li, A. P. / Zhou, J. W. et al. | 2007
- 791
-
Soluble phosphorylated fms-like tyrosine kinase:III. FLT3 protein in patients with acute myeloid leukemia (AML)Ravandi, F. / Jilani, I. / Estey, E. / Kantarjian, H. / Dey, A. / Aguilar, C. / Jitkaroon, C. / Giles, F. / O'Brien, S. / Keating, M. et al. | 2007
- 799
-
The suppressor of cytokine signalling-1 (SOCS-1) gene is overexpressed in Philadelphia chromosome negative chronic myeloproliferative disordersBock, O. / Hussein, K. / Brakensiek, K. / Buhr, T. / Schlue, J. / Wiese, B. / Kreipe, H. et al. | 2007
- 805
-
Apoptosis of T-leukemia and B-myeloma cancer cells induced by hyperbaric oxygen increased phosphorylation of p38 MAPKChen, Y. C. / Chen, S. Y. / Ho, P. S. / Lin, C. H. / Cheng, Y. Y. / Wang, J. K. / Sytwu, H. K. et al. | 2007
- 817
-
Indian black scorpion (Heterometrus bengalensis Koch) venom induced antiproliferative and apoptogenic activity against human leukemic cell lines U937 and K562Das Gupta, S. / Debnath, A. / Saha, A. / Giri, B. / Tripathi, G. / Vedasiromoni, J. R. / Gomes, A. et al. | 2007
- 827
-
Derangement of transcription factor profiles during in vitro differentiation of HL60 and NB4 cellsPass, M. B. / Borregaard, N. / Cowland, J. B. et al. | 2007
- 839
-
Regulation of RUNX1/AML1 during the G2/M transitionWang, S. / Zhang, Y. / Soosairajah, J. / Kraft, A. S. et al. | 2007
- 853
-
Reduced expression of FLIPSHORT in bone marrow of low risk myelodysplastic syndromeCampos, P. d. / Traina, F. / Duarte, A. d. / Lorand-Metze, I. / Costa, F. F. / Saad, S. T. et al. | 2007
- 859
-
HA14-1, a small molecule inhibitor of Bcl-2, bypasses chemoresistance in leukaemia cellsOliver, L. / Mahe, B. / Gree, R. / Vallette, F. M. / Juin, P. et al. | 2007
- 865
-
BCR-ABL mutant kinetics in CML patients treated with dasatinibNicolini, F. E. / Chabane, K. / Tigaud, I. / Michallet, M. / Magaud, J. P. / Hayette, S. et al. | 2007
- 869
-
AML M1 presenting with recurrent acute large arterial vessel thromboembolismReisch, N. / Roehnisch, T. / Sadeghi, M. / Greiner, L. / Regenbogen, C. / Rieger, J. / Emmerich, B. / Oduncu, F. et al. | 2007
- 873
-
Hairy cell leukaemia complicated by anti-MAG paraproteinemic demyelinating neuropathy: resolution of neurological syndrome after cladribrine treatmentRossi, D. / Franceschetti, S. / Cerri, M. / Conconi, A. / Lunghi, M. / Capello, D. / Cantello, R. / Gaidano, G. et al. | 2007
- 877
-
Four novel point mutations in exons 12, 13, and 14 of the FLT3 geneSyampurnawati, M. / Tatsumi, E. / Furuta, K. / Hayashi, Y. et al. | 2007
- 878
-
Chronic myelomonocytic leukemia with overlap dysplastic/proliferative presentationGologan, R. / Stoia, R. / Radulescu, I. / Georgescu, D. / Ostroveanu, D. et al. | 2007
- 881
-
Book reviewFelgar, R. E. et al. | 2007
- 883
-
The dawn of targeted therapy for primary myelofibrosis: Opportunities and challengesMesa, R. A. et al. | 2007
- 887
-
No cell is an island unto itself: The stromal microenvironment in chronic lymphocytic leukemiaBurger, J. A. et al. | 2007
- 889
-
A tribute to Professor David A.G. GaltonBain, B. / Bennett, J. M. / Catovsky, D. / Flandrin, G. et al. | 2007
- 891
-
PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor of vascular endothelial growth factor (VEGF), has modest activity in myelofibrosis with myeloid metaplasiaGiles, F. J. / List, A. F. / Carroll, M. / Cortes, J. E. / Valickas, J. / Chen, B. L. / Masson, E. / Jacques, C. / Laurent, D. / Albitar, M. et al. | 2007
- 899
-
Bone biopsy derived marrow stromal elements rescue chronic lymphocytic leukemia B-cells from spontaneous and drug induced cell death and facilitates an "angiogenic switch"Kay, N. E. / Shanafelt, T. D. / Strege, A. K. / Lee, Y. K. / Bone, N. D. / Raza, A. et al. | 2007
- 907
-
Clinical features and outcome of T-lineage acute lymphoblastic leukemia in adults: A low initial white blood cell count, as well as a high count predict decreased survival ratesYanada, M. / Jinnai, I. / Takeuchi, J. / Ueda, T. / Miyawaki, S. / Tsuzuki, M. / Hatta, Y. / Usui, N. / Wada, H. / Morii, T. et al. | 2007
- 915
-
Clinical significance of a blood eosinophilia in adult T-cell leukemia/lymphoma: A blood eosinophilia is a significant unfavorable prognostic factorUtsunomiya, A. / Ishida, T. / Inagaki, A. / Ishii, T. / Yano, H. / Komatsu, H. / Iida, S. / Yonekura, K. / Takeuchi, S. / Takatsuka, Y. et al. | 2007
- 921
-
HLA-DR-negative AML (M1 and M2): FLT3 mutations (ITD and D835) and cell-surface antigen expressionSyampurnawati, M. / Tatsumi, E. / Furuta, K. / Takenokuchi, M. / Nakamachi, Y. / Kawano, S. / Kumagai, S. / Saigo, K. / Matsui, T. / Takahashi, T. et al. | 2007
- 931
-
Gene expression analysis identifies a genetic signature potentially associated with response to a-IFN in chronic phase CML patientsHagberg, A. / Olsson-Stromberg, U. / Wickenberg-Bolin, U. / Goransson, H. / Isaksson, A. / Bengtsson, M. / Hoglund, M. / Simonsson, B. / Barbany, G. et al. | 2007
- 939
-
T-cell large granular lymphocytic (T-LGL) leukemia: Experience in a single institution over 8 yearsAribi, A. / Huh, Y. / Keating, M. / O'Brien, S. / Ferrajoli, A. / Faderl, S. / Wierda, W. / Kantarjian, H. / Ravandi, F. et al. | 2007
- 947
-
The GST deletions and NQO1*2 polymorphism confers interindividual variability of response to treatment in patients with acute myeloid leukemiaBarragan, E. / Collado, M. / Cervera, J. / Martin, G. / Bolufer, P. / Roman, J. / Sanz, M. A. et al. | 2007
- 955
-
Nucleoside transporter expression and activity is regulated during granulocytic differentiation of NB4 cells in response to all-trans-retinoic acidFlanagan, S. A. / Meckling, K. A. et al. | 2007
- 969
-
Dequalinium induces cell death in human leukemia cells by early mitochondrial alterations which enhance ROS productionSancho, P. / Galeano, E. / Nieto, E. / Delgado, M. D. / Garcia-Perez, A. I. et al. | 2007
- 979
-
Persistent Cdk2 inactivation drives growth arrest of BCR-ABL-expressing cells in response to dual inhibitor of SRC and ABL kinases SKI606Mancini, M. / Brusa, G. / Zuffa, E. / Corrado, P. / Martinelli, G. / Grafone, T. / Barbieri, E. / Santucci, M. A. et al. | 2007
- 989
-
Simultaneous suppression of multidrug resistance and antiapoptotic cellular defense induces apoptosis in chemoresistant human acute myeloid leukemia cellsWang, X. / Wang, C. / Qin, Y. w. / Yan, S. k. / Gao, Y. r. et al. | 2007
- 995
-
Expression of the IFN-inducible p53-target gene TRIM22 is down-regulated during erythroid differentiation of human bone marrowObad, S. / Olofsson, T. / Mechti, N. / Gullberg, U. / Drott, K. et al. | 2007
- 1003
-
Antiproliferative and apoptotic effects of mycophenolic acid in human B-cell non-Hodgkin lymphomasVegs, G. / Sebestyen, A. / Paku, S. / Barna, G. / Hajdu, M. / Toth, M. / Jaray, J. / Kopper, L. et al. | 2007
- 1009
-
Switch in X-inactivation in a JAK2 V617F-negative case of polycythemia vera with two acquired X-autosome translocationsManola, K. N. / Stavropoulou, C. / Georgakakos, V. N. / Zoi, K. / Fisfis, M. / Evmorfiadis, I. / Zoi, C. / Pantelias, G. E. / Stefanoudaki, K. / Sambani, C. et al. | 2007
- 1015
-
FLT3 mutation and AML/ETO in a case of Myelodysplastic syndrome in transformation corroborates the two hit model of leukemogenesisPinheiro, R. F. / Moreira, E. d. / Silva, M. R. / Greggio, B. / Alberto, F. L. / Chauffaille, M. d. et al. | 2007
- 1019
-
Simultaneous diagnosis of CD3+ T-cell large granular lymphocyte leukaemia and true thymic hyperplasiaRossi, D. / Franceschetti, S. / Capello, D. / Conconi, A. / Casadio, C. / Valente, G. / Gaidano, G. et al. | 2007
- 1023
-
Therapeutic responses in childhood acute lymphoblastic leukemia (ALL) and haplotypes of gamma glutamyl hydrolase (GGH) geneGarcia-Bournissen, F. / Moghrabi, A. / Krajinovic, M. et al. | 2007
- 1025
-
Campath-1H induced pure red cell aplasia in a patient with chronic lymphatic leukaemiaThachil, J. / Salim, R. et al. | 2007
- 1026
-
Bortezomib inhibits T-cell function versus infective antigenic stimuli in a dose-dependent manner in vitroOrciuolo, E. / Galimberti, S. / Petrini, M. et al. | 2007
- 1027
-
Severe pulmonary complications after bortezomib treatment for multiple myeloma: An unrecognized pulmonary vasculitis?Pitini, V. / Arrigo, C. / Altavilla, G. / Naro, C. et al. | 2007
- 1029
-
NQO1*2 polymorphism and response to treatment in patients with multiple myelomaBuda, G. / Maggini, V. / Galimberti, S. / Barale, R. / Rossi, A. M. / Petrini, M. et al. | 2007
- 1031
-
WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disordersMichiels, J. J. / De Raeve, H. / Hebeda, K. / Lam, K. H. / Berneman, Z. / Schroyens, W. / Schwarz, J. et al. | 2007
- 1039
-
Inactivation of p14ARF as a key event for the progression of adult T cell leukemia/lymphomaKohno, T. / Yamada, Y. / Tawara, M. / Takasaki, Y. / Kamihira, S. / Tomonaga, M. / Matsuyama, T. et al. | 2007
- 1047
-
What is stage II in high-grade primary gastric lymphoma?:How to define the range of "localized disease"Park, Y. H. / Kim, W. S. / Bang, S. M. / Lee, S. I. / Uhm, J. E. / Yang, S. H. / Lee, S. S. / Park, K. / Ko, Y. H. / Ryoo, B. Y. et al. | 2007
- 1053
-
Increased midkine gene expression in childhood B-precursor acute lymphoblastic leukemiaHidaka, H. / Yagasaki, H. / Takahashi, Y. / Hama, A. / Nishio, N. / Tanaka, M. / Yoshida, N. / Villalobos, I. B. / Wang, Y. / Xu, Y. et al. | 2007
- 1061
-
Correlations of JAK2-V617F mutation with clinical and laboratory findings in patients with myeloproliferative disordersSpeletas, M. / Katodritou, E. / Daiou, C. / Mandala, E. / Papadakis, E. / Kioumi, A. / Ritis, K. / Korantzis, I. et al. | 2007
- 1071
-
High dose melphalan or intermediate dose melphalan can be well tolerated and result in good response rates in selected elderly patients with myelomaBishton, M. / Gilyead, M. / Das Gupta, E. / Williams, C. / Russell, N. H. / Byrne, J. L. et al. | 2007
- 1077
-
High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myelomaBenson, D. M. / Elder, P. J. / Lin, T. S. / Blum, W. / Penza, S. / Avalos, B. / Copelan, E. / Farag, S. S. et al. | 2007
- 1085
-
Tyk2 mutation homologous to V617F Jak2 is not found in essential thrombocythaemia, although it induces constitutive signaling and growth factor independenceShide, K. / Shimoda, K. / Kamezaki, K. / Kakumitsu, H. / Kumano, T. / Numata, A. / Ishikawa, F. / Takenaka, K. / Yamamoto, K. / Matsuda, T. et al. | 2007
- 1093
-
N-Benzyladriamycin-14-valerate (AD 198) cytotoxicty circumvents Bcr-Abl anti-apoptotic signaling in human leukemia cells and also potentiates imatinib cytotoxicityLothstein, L. / Savranskaya, L. / Sweatman, T. W. et al. | 2007
- 1105
-
Characteristics of novel myeloid precursor cell line, PC-MDS, established from a bone marrow of the patient with therapy-related myelodysplastic syndromeBogdanovic, G. / Jurisic, V. / Kraguljac, N. / Mrdjanovic, J. / Jakimov, D. / Krtolica, K. / Krajnovic, M. / Magic, Z. / Stojiljkovic, B. / Andrijevic, L. et al. | 2007
- 1115
-
The GAP-related domain of neurofibromin attenuates proliferation and downregulates N- and K-Ras activation in Nf1-negative AML cellsMorgan, K. J. / Rowley, M. A. / Wiesner, S. M. / Hasz, D. E. / Van Ness, B. / Largaespada, D. A. et al. | 2007
- 1123
-
Pivanex, a histone deacetylase inhibitor, induces changes in BCR-ABL expression and when combined with STI571, acts synergistically in a chronic myelocytic leukemia cell lineRabizadeh, E. / Merkin, V. / Belyaeva, I. / Shaklai, M. / Zimra, Y. et al. | 2007
- 1133
-
XIAP is upregulated in HL-60 cells cocultured with stromal cells by direct cell contactWang, X. / Wang, C. / Yan, S. K. / Gao, Y. R. et al. | 2007
- 1139
-
Dual treatment with FLT3 inhibitor SU11657 and doxorubicin increases survival of leukemic miceLee, B. D. / Sevcikova, S. / Kogan, S. C. et al. | 2007
- 1143
-
Erythroleukaemia, diabetes insipidus and hypophyseal damage: Two case reportsPiccin, A. / Raimondi, R. / Laspina, S. / Marchi, M. / Rodeghiero, F. / Rovigatti, U. et al. | 2007
- 1149
-
Therapy-related myelodysplastic syndrome and acute myeloid leukemia following initial treatment with chemotherapy plus radioimmunotherapy for indolent non-Hodgkin lymphomaRoboz, G. J. / Bennett, J. M. / Coleman, M. / Ritchie, E. K. / Furman, R. R. / Rossi, A. / Jhaveri, K. / Feldman, E. J. / Leonard, J. P. et al. | 2007
- 1153
-
An MLL-SEPT9 fusion and t(11;17)(q23;q25) associated with de novo myelodysplastic syndromeKreuziger, L. M. / Porcher, J. C. / Ketterling, R. P. / Steensma, D. P. et al. | 2007
- 1157
-
Systemic antineutrophil cytoplasmic antibody vasculitis in a patient with chronic lymphocytic leukemia:Quite a rare diagnosisPamuk, G. E. / Uyank, M. S. / Demir, M. / Tekgunduz, E. / Turgut, B. / Soy, M. et al. | 2007
- 1161
-
Bortezomib and extramedullary disease in multiple myeloma: The shine and dark side of the moonAli, R. / Ozkalemkas, F. / Ozkan, A. / Ozkocaman, V. / Ozcelik, T. / Ozan, U. / Kurt, M. / Tunali, A. et al. | 2007
- 1163
-
CXCR4 expression during tumour cell deathSkommer, J. / Wlodkowic, D. / Pelkonen, J. et al. | 2007
- 1164
-
A new strategy to resume the apoptosis activity of p53 in leukemia cell lines retaining wild-type p53Liu, Z. J. / Xin, H. M. / Chen, J. / Lu, X. / Zhong, S. / Gu, S. Z. / Wang, G. / Liu, L. / Cai, Y. / Hou, L. et al. | 2007
- 1166
-
D104N polymorphism in endostatin, an angiogenesis inhibitor, in acute and chronic myeloid leukaemiaNascimento, H. / Lourenco, G. J. / Ortega, M. M. / Yamaguti, G. G. / Costa, F. F. / Lima, C. S. et al. | 2007
- 1168
-
Involvement of Notch signaling in myelodysplastic syndromeFu, L. / Nara, N. / Tohda, S. et al. | 2007
- 1171
-
A new era for ribonucleoside reductase inhibitionGiles, F. J. et al. | 2007
- 1173
-
Phase I and pharmacokinetic study of Triapine, a potent ribonucleotide reductase inhibitor, in adults with advanced hematologic malignanciesGojo, I. / Tidwell, M. L. / Greer, J. / Takebe, N. / Seiter, K. / Pochron, M. F. / Johnson, B. / Sznol, M. / Karp, J. E. et al. | 2007
- 1183
-
Quantification of mixed chimerism by real time PCR on whole blood-impregnated FTA cardsPezzoli, N. / Silvy, M. / Woronko, A. / Le Treut, T. / Levy-Mozziconacci, A. / Reviron, D. / Gabert, J. / Picard, C. et al. | 2007
- 1193
-
Efficacy of conventional cytogenetics and FISH for EGR1 to detect deletion 5q in hematological disorders and to assess response to treatment with LenalidomideZou, Y. S. / Fink, S. R. / Stockero, K. J. / Paternoster, S. F. / Smoley, S. A. / Tun, H. W. / Reeder, C. B. / Tefferi, A. / Dewald, G. W. et al. | 2007
- 1199
-
Prognostic impact of chromosomal alteration of 3q27 on nodal B-cell lymphoma: Correlation with histology, immunophenotype, karyotype, and clinical outcome in 329 consecutive patientsNiitsu, N. / Okamoto, M. / Nakamura, N. / Nakamine, H. / Aoki, S. / Hirano, M. / Miura, I. et al. | 2007
- 1207
-
Pro-inflammatory cytokinemia is frequently found in Down syndrome patients with hematological disordersShimada, A. / Hayashi, Y. / Ogasawara, M. / Park, M. j. / Katoh, M. / Minakami, H. / Kitoh, T. / Kojima, S. / Kawa, K. / Kimura, H. et al. | 2007
- 1213
-
Rapid screening and sensitive detection of NPM1 (nucleophosmin) exon 12 mutations in acute myeloid leukaemiaScholl, S. / Mugge, L. O. / Landt, O. / Loncarevic, I. F. / Kunert, C. / Clement, J. H. / Hoffken, K. et al. | 2007
- 1221
-
MTHFR 677CC/1298CC genotypes are highly associated with chronic myelogenous leukemia: A case-control study in KoreaMoon, H. W. / Kim, T. Y. / Oh, B. R. / Min, H. C. / Cho, H. I. / Bang, S. M. / Lee, J. H. / Yoon, S. S. / Lee, D. S. et al. | 2007
- 1227
-
Detailed assessment of copy number alterations revealing homozygous deletions in 1p and 13q in mantle cell lymphomaFlordal Thelander, E. / Ichimura, K. / Collins, V. P. / Walsh, S. H. / Barbany, G. / Hagberg, A. / Laurell, A. / Rosenquist, R. / Larsson, C. / Lagercrantz, S. et al. | 2007
- 1239
-
Immunoglobulin light chain repertoire in hairy cell leukemiaArons, E. / Suntum, T. / Sunshine, J. / Stetler-Stevenson, M. / Kreitman, R. J. et al. | 2007
- 1245
-
Chemokine system and tissue infiltration in aggressive NK-cell leukemiaMakishima, H. / Ito, T. / Momose, K. / Nakazawa, H. / Shimodaira, S. / Kamijo, Y. / Nakazawa, Y. / Ichikawa, N. / Ueno, M. / Kobayashi, H. et al. | 2007
- 1255
-
Use of IGHJ and IGHD gene mutations in analysis of immunoglobulin sequences for the prognosis of chronic lymphocytic leukemiaLee, C. E. / Jackson, K. J. / Sewell, W. A. / Collins, A. M. et al. | 2007
- 1261
-
Is there a plateau in the survival curve after autologous transplantation in patients with intermediate and high-risk acute myeloid leukemia? A 20-year single institution experienceGanguly, S. / Singh, J. / Divine, C. L. / Deauna-Limayo, D. / Bodensteiner, D. C. / Lewis, J. L. / Curran, K. / Skikne, B. S. et al. | 2007
- 1267
-
Coordination of upregulated XBP-1 and downregulated c-myc during myeloma cell differentiation induced by 2-methoxyestradiolZhou, X. / Jiang, H. / Hou, J. et al. | 2007
- 1275
-
Balance of NF-kappaB and p38 MAPK is a determinant of radiosensitivity of the AML-2 and its doxorubicin-resistant cell linesChoi, C. H. / Xu, H. / Bark, H. / Lee, T. B. / Yun, J. / Kang, S. I. / Oh, Y. K. et al. | 2007
- 1285
-
Inhibition of HuR and MMP-9 expression in macrophage-differentiated HL-60 myeloid leukemia cells by green tea polyphenol EGCgAnnabi, B. / Currie, J. C. / Moghrabi, A. / Beliveau, R. et al. | 2007
- 1293
-
Establishment of a human herpes virus-8-negative malignant effusion lymphoma cell line (STR-428) carrying concurrent translocations of BCL2 and c-MYC genesTaira, T. / Nagasaki, A. / Tomoyose, T. / Miyagi, J. i. / Kakazu, N. / Makino, S. / Shinjyo, T. / Taira, N. / Masuda, M. / Takasu, N. et al. | 2007
- 1301
-
Lack of mitochondrial depolarization by oxidative stress is associated with resistance to buthionine sulfoximine in acute lymphoblastic leukemia cellsGoto, H. / Yanagimachi, M. / Kajiwara, R. / Kuroki, F. / Yokota, S. et al. | 2007
- 1311
-
Clonogenic acute myelogenous leukemia cells are heterogeneous with regard to regulation of differentiation and effect of epigenetic pharmacological targetingRyningen, A. / Stapnes, C. / Bruserud, O. et al. | 2007
- 1323
-
Could ATRA/Idarubicin treatment of acute promyelocytic leukemia induce the appearance of new clonal cytogenetic abnormalities in patients in complete remission?Mallo, M. / Salido, M. / Espinet, B. / Cervera, J. / Canellas, A. / Pajuelo, J. C. / Pedro, C. / Florensa, L. / Sanz, M. A. / Sole, F. et al. | 2007
- 1325
-
Prognostic signature of ALL blasts at diagnosis: What can we really find?Gandemer, V. / de Tayrac, M. / Mosser, J. / Galibert, M. D. et al. | 2007
- 1325
-
What does over-expression of cN-II enzyme signify in haematological malignancies?Galmarini, C. M. et al. | 2007
- 1327
-
On the evidence for seasonal variation in the onset of acute lymphoblastic leukemia (ALL)Gao, F. / Chia, K. S. / Machin, D. et al. | 2007
- 1327
-
A patient with de novo AML M1 and t(16;21) with karyotype evolutionZatkova, A. / Fonatsch, C. / Sperr, W. R. / Valent, P. et al. | 2007
- 1329
-
Match unrelated bone marrow transplantation in a case of high risk myelodysplastic syndrome treated with azacitidine and concomitant 1a-25-dihydroxyvitamin D3, as differentiating agentOrciuolo, E. / Cecconi, N. / Galimberti, S. / Papineschi, F. / Petrini, M. et al. | 2007
- 1331
-
Mutation analysis of CUTL1 in childhood myeloid neoplasias with monosomy 7Hindersin, S. / Niemeyer, C. M. / Germing, U. / Gobel, U. / Kratz, C. P. et al. | 2007
- 1339
-
Giulio Bizzozero and the discovery of plateletsRibatti, D. / Crivellato, E. et al. | 2007
- 1343
-
Clinical significance of high-Km 5prime-nucleotidase (cN-II) mRNA expression in high-risk myelodysplastic syndromeSuzuki, K. / Sugawara, T. / Oyake, T. / Uchiyama, T. / Aoki, Y. / Tsukushi, Y. / Onodera, S. / Ito, S. / Murai, K. / Ishida, Y. et al. | 2007
- 1351
-
Comparison of minimal residual disease (MRD) estimated by flow cytometry and by real-time quantitative PCR of Wilms tumor gene 1 (WT1) transcript expression in children with acute lymphoblastic leukemiaChen, J. S. / Hsiao, C. C. / Sheen, J. M. / Cheng, C. N. et al. | 2007
- 1359
-
Increased frequencies of glutathione-S-transferase (GSTM1 and GSTT1) null genotypes in Indian patients with chronic myeloid leukemiaBajpai, P. / Tripathi, A. K. / Agrawal, D. et al. | 2007
- 1365
-
Birth order, allergies and lymphoma risk: Results of the European collaborative research project EpilymphBecker, N. / de Sanjose, S. / Nieters, A. / Maynadie, M. / Foretova, L. / Cocco, P. L. / Staines, A. / Alvaro, T. / Vornanen, M. / Brennan, P. et al. | 2007
- 1373
-
Immature and mature monocyte-derived dendritic cells in myelodysplastic syndromes of subtypes refractory anemia or refractory anemia with ringed sideroblasts display an altered cytokine profileMa, L. / Ceuppens, J. / Kasran, A. / Delforge, M. / Boogaerts, M. / Vandenberghe, P. et al. | 2007
- 1383
-
Effect of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming (CAG regimen) on the outcome of elderly patients with acute myeloid leukemiaQian, S. X. / Li, J. Y. / Tian, T. / Shen, Y. F. / Jiang, Y. Q. / Lu, H. / Wu, H. X. / Zhang, S. J. / Xu, W. et al. | 2007
- 1389
-
Global cytokine analysis in myeloproliferative disordersHo, C. L. / Lasho, T. L. / Butterfield, J. H. / Tefferi, A. et al. | 2007
- 1393
-
Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysisRohner, A. / Langenkamp, U. / Siegler, U. / Kalberer, C. P. / Wodnar-Filipowicz, A. et al. | 2007
- 1403
-
Downregulation of c-Myc is critical for valproic acid-induced growth arrest and myeloid differentiation of acute myeloid leukemiaCheng, Y. C. / Lin, H. / Huang, M. J. / Chow, J. M. / Lin, S. / Liu, H. E. et al. | 2007
- 1413
-
Involvement of c-Jun N-terminal kinase in G2/M arrest and FasL-mediated apoptosis induced by a novel indoloquinoline derivative, IQDMA, in K562 cellsYang, S. H. / Chien, C. M. / Lu, C. M. / Chen, Y. L. / Chang, L. S. / Lin, S. R. et al. | 2007
- 1421
-
Retinoic acid enhances differentiation of v-myb-transformed monoblasts induced by okadaic acidBenes, P. / Maceckova, V. / Zatloukalova, J. / Kovarova, L. / Smardova, J. / Smarda, J. et al. | 2007
- 1433
-
Incidence of hyperthyroidism after unrelated donor allogeneic stem cell transplantationPerz, J. B. / Marin, D. / Szydlo, R. M. / Giles, C. / Olavarria, E. / Williams, G. / Apperley, J. F. et al. | 2007
- 1437
-
Expression of matrix metalloproteinase (MMP) and tissue inhibitor of MMP (TIMP) genes in blasts of infant acute lymphoblastic leukemia with organ involvementSuminoe, A. / Matsuzaki, A. / Hattori, H. / Koga, Y. / Ishii, E. / Hara, T. et al. | 2007
- 1441
-
Synergistic interactions between 12-0-tetradecanoylphorbol-13-acetate (TPA) and imatinib in patients with chronic myeloid leukemia in blastic phase that is resistant to standard-dose imatinibFang, B. / Song, Y. / Han, Z. / Wei, X. / Lin, Q. / Zhu, X. / Yang, R. / Sun, J. / Tian, G. / Liu, X. et al. | 2007
- 1445
-
What is the best salvage therapy for treatment of isolated CNS relapse in elderly patients with imatinib-responsive Ph+ ALL?Mele, G. / Pinna, S. / Melpignano, A. / Romano, A. / Brocca, M. C. / Coppi, M. R. / Quarta, G. et al. | 2007
- 1449
-
Targeting the Na+/H+ exchanger: An old concept with new perspectives in the treatment of hematological malignanciesTurturro, F. / Lawson, M. / Friday, E. / Welbourne, T. et al. | 2007
- 1450
-
Chlamydia psittaci, Helicobacter pylori and ocular adnexal lymphoma-is there an association?:The German experienceGoebel, N. / Serr, A. / Mittelviefhaus, H. / Reinhard, T. / Bogdan, C. / Auw-Haedrich, C. et al. | 2007
- 1452
-
Reduced elimination of Methotrexate in an adult with trisomy 21 and acute lymphoblastic leukaemiaThachil, J. et al. | 2007
- 1453
-
PEG-Filgrastim activity on granulocyte functionsFazzi, R. / Orciuolo, E. / Trombi, L. / Mattii, L. / Battola, B. / Riccioni, R. / Carulli, G. / Galimberti, S. / Petrini, M. et al. | 2007
- 1457
-
Corrigendum to "Antineoplastic effect of a single oral dose of the novel Flt3 inhibitor KRN383 on xenografted human leukemic cells harboring Flt3-activating mutations" [Leuk. Res. 30 (2006) 1541-1546]Nishiyama, U. / Yoshino, T. / Ozai, M. / Yoshioka, R. / Fujisawa, M. / Ogasawara, Y. / Kitahori, M. / Yoshioka, E. / Kubo, K. / Komeno, Y. et al. | 2007
- 1459
-
Angiogenesis revisited in CLLKay, N. E. et al. | 2007
- 1461
-
Idiopathic cytopenia of undetermined significance (ICUS) versus low risk MDS: The diagnostic interfaceWimazal, F. / Fonatsch, C. / Thalhammer, R. / Schwarzinger, I. / Mullauer, L. / Sperr, W. R. / Bennett, J. M. / Valent, P. et al. | 2007
- 1469
-
Impairment in immuno-modulatory function of Flk1+CD31-CD34- MSCs from MDS-RA patientsHan, Q. / Sun, Z. / Liu, L. / Chen, B. / Cao, Y. / Li, K. / Zhao, R. C. et al. | 2007
- 1479
-
The TNF-a 238A polymorphism is associated with susceptibility to persistent bone marrow dysplasia following chronic exposure to benzeneLv, L. / Kerzic, P. / Lin, G. / Schnatter, A. R. / Bao, L. / Yang, Y. / Zou, H. / Fu, H. / Ye, X. / Gross, S. A. et al. | 2007
- 1487
-
Peg-filgrastim versus filgrastim after autologous stem cell tranplantation: Case-control study in patients with multiple myeloma and review of the literatureMusto, P. / Scalzulli, P. R. / Terruzzi, E. / Rossini, F. / Iacopino, P. / Messina, G. / Guariglia, R. / Pietrantuono, G. / Villani, O. / D'Auria, F. et al. | 2007
- 1495
-
Survivin and EPR-1 expression in acute leukemias: Prognostic significance and review of the literatureOto, O. A. / Paydas, S. / Tanriverdi, K. / Seydaoglu, G. / Yavuz, S. / Disel, U. et al. | 2007
- 1503
-
Monocytosis is an adverse prognostic factor for survival in younger patients with primary myelofibrosisElliott, M. A. / Verstovsek, S. / Dingli, D. / Schwager, S. M. / Mesa, R. A. / Li, C. Y. / Tefferi, A. et al. | 2007
- 1511
-
Comparative gene expression analysis of a chronic myelogenous leukemia cell line resistant to cyclophosphamide using oligonucleotide arrays and response to tyrosine kinase inhibitorsBao, F. / Polk, P. / Nordberg, M. L. / Veillon, D. M. / Sun, A. / Deininger, M. / Murray, D. / Andersson, B. S. / Munker, R. et al. | 2007
- 1521
-
Epigenetic regulation of PRAME gene in chronic myeloid leukemiaRoman-Gomez, J. / Jimenez-Velasco, A. / Agirre, X. / Castillejo, J. A. / Navarro, G. / Jose-Eneriz, E. S. / Garate, L. / Cordeu, L. / Cervantes, F. / Prosper, F. et al. | 2007
- 1529
-
Targeting NF-kB and induction of apoptosis by novel NF-kB inhibitor dehydroxymethylepoxyquinomicin (DHMEQ) in Burkitt lymphoma cellsKimura, N. / Miyakawa, Y. / Kohmura, K. / Umezawa, K. / Ikeda, Y. / Kizaki, M. et al. | 2007
- 1537
-
Segregation of megakaryocytic or erythroid cells from a megakaryocytic leukemia cell line (JAS-R) by adhesion during cultureYamada, H. / Sekikawa, T. / Iwase, S. / Arakawa, Y. / Suzuki, H. / Agawa, M. / Akiyama, M. / Takeda, N. / Horiguchi-Yamada, J. et al. | 2007
- 1545
-
Limited antitumor-effect associated with toxicity of the experimental cytotoxic drug cyclopentenyl cytosine in NOD/scid mice with acute lymphoblastic leukemiaSchimmel, K. J. / Nijmeijer, B. A. / van Schie, M. L. / Falkenburg, J. H. / Guchelaar, H. J. et al. | 2007
- 1553
-
Effects of AMD3100 on transmigration and survival of acute myelogenous leukemia cellsLiesveld, J. L. / Bechelli, J. / Rosell, K. / Lu, C. / Bridger, G. / Phillips, G. / Abboud, C. N. et al. | 2007
- 1565
-
Therapeutic efficacy of NSC606985, a novel camptothecin analog, in a mouse model of acute promyelocytic leukemiaLiu, W. / Zhu, Y. S. / Guo, M. / Yu, Y. / Chen, G. Q. et al. | 2007
- 1575
-
Markers of increased angiogenesis and their correlation with biological parameters identifying high-risk patients in early B-cell chronic lymphocytic leukemiaMolica, S. / Cutrona, G. / Vitelli, G. / Mirabelli, R. / Molica, M. / Digiesi, G. / Ribatti, D. / Ferrarini, M. / Vacca, A. et al. | 2007
- 1579
-
The GCB subtype of diffuse large B-cell lymphoma is less frequent in Asian countriesShiozawa, E. / Yamochi-Onizuka, T. / Takimoto, M. / Ota, H. et al. | 2007
- 1585
-
Arsenic in the cerebrospinal fluid of a patient receiving arsenic trioxide for relapsed acute promyelocytic leukemia with CNS involvementKnipp, S. / Gattermann, N. / Schapira, M. / Kaferstein, H. / Germing, U. et al. | 2007
- 1589
-
Acute myeloid leukemia developing during imatinib mesylate therapy for chronic myeloid leukemia in the absence of new cytogenetic abnormalitiesPawarode, A. / Sait, S. N. / Nganga, A. / Coignet, L. J. / Barcos, M. / Baer, M. R. et al. | 2007
- 1593
-
Essential thrombocythemia after treatment of non-Hodgkins lymphomaMaciel, J. F. / de Lourdes Chauffaille, M. / Inaoka, R. J. / Colleoni, G. W. / Yamamoto, M. et al. | 2007
- 1595
-
RAF-1 over-expression does condition survival of patients affected by aggressive mantle cell lymphomaNagy, B. / Galimberti, S. / Benedetti, E. / Caracciolo, F. / Pacini, S. / Vilpo, J. / Ferrer, A. / Elonen, E. / Franssila, K. / Knuutila, S. et al. | 2007
- 1597
-
Unusual association of MLL rearrangement and secondary myelomonocytic leukemia in a 15-year-old patient treated for osteosarcomaBrichard, B. / Poirel, H. A. / Chantrain, C. / Dupont, S. / Libouton, J. M. / Scheiff, J. M. / Vermylen, C. et al. | 2007
- 1599
-
A therapy resistant myelodysplastic syndrome characterized by the presence of the rare reciprocal translocation t(3;12)(q26.2;p13)Orciuolo, E. / Buda, G. / Cecconi, N. / Galimberti, S. / Petrini, M. et al. | 2007
- 1600
-
Nelarabine activity in acute biphenotypic leukemiaAlvarado, Y. / Welch, M. A. / Swords, R. / Bruzzi, J. / Schlette, E. / Giles, F. J. et al. | 2007
- 1603
-
Skin and stomach graft versus host disease after syngeneic BMT in CML: A case reportPelosini, M. / Galimberti, S. / Benedetti, E. / Caracciolo, F. / Fazzi, R. / Petrini, M. / Papineschi, F. et al. | 2007
- 1604
-
TPL-2 MEK kinase is not targeted by mutation in diffuse large B cell lymphoma and myeloid leukemiaShirali, S. / Hamoudi, R. A. / Bench, A. / Scott, M. / Ley, S. C. / Du, M. Q. et al. | 2007
- 1609
-
Diagnostic value of histology and immunohistochemistry in myelodysplastic syndromesHorny, H. P. / Sotlar, K. / Valent, P. et al. | 2007
- 1617
-
A new look at apoptosis in MDS; an uneasy neighborYoshida, Y. et al. | 2007
- 1621
-
On the mutagenic action of adenineParry, T. E. et al. | 2007
- 1633
-
Regulatory polymorphisms of multidrug resistance 1 (MDR1) gene are associated with the development of childhood acute lymphoblastic leukemiaHattori, H. / Suminoe, A. / Wada, M. / Koga, Y. / Kohno, K. / Okamura, J. / Hara, T. / Matsuzaki, A. et al. | 2007
- 1641
-
Increased apoptosis of circulating T cells in myelodysplastic syndromesShioi, Y. / Tamura, H. / Yokose, N. / Satoh, C. / Dan, K. / Ogata, K. et al. | 2007
- 1649
-
Does p16ink4a expression increase with the number of cell doublings in normal and malignant lymphocytes?Chebel, A. / Chien, W. W. / Gerland, L. M. / Mekki, Y. / Bertrand, Y. / Ffrench, P. / Galmarini, C. M. / Ffrench, M. et al. | 2007
- 1659
-
Bone marrow mononuclear cells of MDS patients are characterized by in vitro proliferation and increased apoptosis independently of stromal interactionsSpan, L. F. / Rutten, E. / Gemmink, A. / Boezeman, J. B. / Raymakers, R. A. / de Witte, T. et al. | 2007
- 1669
-
MTHFR polymorphisms' influence on outcome and toxicity in acute lymphoblastic leukemia patientsChiusolo, P. / Reddiconto, G. / Farina, G. / Mannocci, A. / Fiorini, A. / Palladino, M. / La Torre, G. / Fianchi, L. / Sora, F. / Laurenti, L. et al. | 2007
- 1675
-
Evidence that a BCR-ABL fusion peptide does not induce lymphocyte proliferation or cytokine production in vitroAbu-Eisha, H. M. / Butt, N. M. / Clark, R. E. / Christmas, S. E. et al. | 2007
- 1683
-
Clustering in the incidence of myelodysplastic syndromesMa, X. / Selvin, S. / Raza, A. / Foti, K. / Mayne, S. T. et al. | 2007
- 1687
-
Brefeldin A triggers apoptosis associated with mitochondrial breach and enhances HA14-1- and anti-Fas-mediated cell killing in follicular lymphoma cellsWlodkowic, D. / Skommer, J. / Pelkonen, J. et al. | 2007
- 1701
-
Role of glycosylphosphatidylinositol-specific phospholipase D in the homing of umbilical cord blood, mobilized peripheral blood and bone marrow-derived hematopoietic stem/progenitor cellsSong, K. / Sun, X. / Wang, J. / Zhou, S. / Zeng, H. / Chen, F. et al. | 2007
- 1709
-
A novel canine lymphoma cell line: A translational and comparative model for lymphoma researchKisseberth, W. C. / Nadella, M. V. / Breen, M. / Thomas, R. / Duke, S. E. / Murahari, S. / Kosarek, C. E. / Vernau, W. / Avery, A. C. / Burkhard, M. J. et al. | 2007
- 1721
-
Increased responsiveness to TLR2 and TLR4 ligands during dimethylsulfoxide-induced neutrophil-like differentiation of HL-60 myeloid leukemia cellsShuto, T. / Furuta, T. / Cheung, J. / Gruenert, D. C. / Ohira, Y. / Shimasaki, S. / Suico, M. A. / Sato, K. / Kai, H. et al. | 2007
- 1729
-
Caspase-8 dependent apoptosis induction in malignant myeloid cells by TLR stimulation in the presence of IFN-alphaLehner, M. / Bailo, M. / Stachel, D. / Roesler, W. / Parolini, O. / Holter, W. et al. | 2007
- 1737
-
Expression of TCL-1 as a potential prognostic factor for treatment outcome in B-cell chronic lymphocytic leukemiaBrowning, R. L. / Geyer, S. M. / Johnson, A. J. / Jelinek, D. F. / Tschumper, R. C. / Call, T. G. / Shanafelt, T. D. / Zent, C. S. / Bone, N. D. / Dewald, G. W. et al. | 2007
- 1741
-
Gene expression profiles that segregate patients with childhood acute lymphoblastic leukaemia: An independent validation study identifies that endoglin associates with patient outcomeCatchpoole, D. / Lail, A. / Guo, D. / Chen, Q. R. / Khan, J. et al. | 2007
- 1749
-
Distinct clonal origins of systemic mastocytosis and associated B-cell lymphomaKim, Y. / Weiss, L. M. / Chen, Y. Y. / Pullarkat, V. et al. | 2007
- 1755
-
Systemic mastocytosis in association with chronic lymphocytic leukemia: A rare diagnosisAult, P. / Lynn, A. / Tam, C. S. / Medeiros, L. J. / Keating, M. J. et al. | 2007
- 1759
-
Multiple signal pathways in the leukemogenesis and therapeutic implicationsChen, J. / McMillan, N. A. et al. | 2007
- 1761
-
Association of PIM gene translocation and TEL/AML1 rearrangementBuda, G. / Orciuolo, E. / Galimberti, S. / Carulli, G. / Petrini, M. et al. | 2007
- 1763
-
Modern prognostic factors and angiogenesis in chronic lymphocytic leukemia: More data neededSmolej, L. / Andrys, C. / Vroblova, V. et al. | 2007
- 1765
-
Poor prognosis chronic myeloid leukemia with a complex variant Philadelphia translocation, t(9;10;22)(q34;q24;q11)Buda, G. / Orciuolo, E. / Cecconi, N. / Galimberti, S. / Cervetti, G. / Petrini, M. et al. | 2007
- 1766
-
No effect of platelet-activating factor on the proliferation and apoptosis of immature forms of leukemic blastsTruffinet, V. / Vincent, C. / Donnard, M. / Bordessoule, D. / Turlure, P. / Trimoreau, F. / Denizot, Y. et al. | 2007
- 1768
-
Bone marrow necrosis related to imatinib mesylate therapy for cml bilineal blast crisisCampiotti, L. / Codari, R. / Appio, L. / Ultori, C. / Solbiati, F. / Maria Grandi, A. / Venco, A. et al. | 2007
- 1770
-
Impaired fasting glucose level as metabolic side effect of nilotinib in non-diabetic chronic myeloid leukemia patients resistant to imatinibBreccia, M. / Muscaritoli, M. / Gentilini, F. / Latagliata, R. / Carmosino, I. / Fanelli, F. R. / Alimena, G. et al. | 2007
- S1
-
Therapy-related myelodysplasiaPedersen-Bjergaard, J. et al. | 2007
- S2
-
Impact of transfusion dependency and secondary iron overload on the survival of patients with myelodysplastic syndromesMalcovati, L. et al. | 2007
- S3
-
E01 Biology, cytogenetics and molecular studies in acute myeloid leukemiaMrozek, K. / Paschka, P. / Marcussi, G. / Whitman, S. P. / Bloomfield, C. D. et al. | 2007
- S7
-
E02 Autologous haematopoetic cell transplantation for acute myeloblastic leukaemiaHolowiecki, J. et al. | 2007
- S7
-
Improving clinical outcome in patients with myelodysplastic syndrome and iron overload using iron chelation therapyLeitch, H. A. et al. | 2007
- S9
-
E03 Treatment of Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL)Ottman, O. et al. | 2007
- S10
-
Guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overloadGattermann, N. et al. | 2007
- S10
-
E04 Early aggressive chemotherapy seen as the key to advanced Hodgkin lymphoma relapse ratesDiehl, V. et al. | 2007
- S12
-
E05 New issues in the management of localized Hodgkins lymphomaCanellos, G. P. et al. | 2007
- S13
-
E06 Unrelated donor (MUD) haematopoietic stem cell transplantation in patients with myeloid malignanciesPetersen, F. B. et al. | 2007
- S15
-
E07 Stem cell transplantation in ALL: a donor versus no donor comparison in the EORTC ALL-4 studyLabar, B. / Suciu, S. / Muus, P. / Willemze, R. / Marie, J. P. / Fillet, G. / Berneman, Z. / Jaksic, B. / Feremans, W. / Bron, D. et al. | 2007
- S16
-
E08 New tyrosine kinase inhibitors in chronic myeloid leukemia (CML)Kantarjian, H. / Cortes, J. et al. | 2007
- S16
-
Novel treatment options for transfusional iron overload in patients with myelodysplastic syndromesGoldberg, S. L. et al. | 2007
- S19
-
E09 Insights into the pathogenesis & therapy of myeloproliferative disease from mouse modelsZaleskas, V. / Chan, W. / Patel, N. / Lazarides, K. / Murre, C. / Van Etten, R. et al. | 2007
- S20
-
E10 Stem cell transplantation for multiple myeloma in Croatia: evaluation of the efficacy of double autologous stem cell transplantationNemet, D. / Sertic, D. / Mrsic, M. / Bojanic, I. / Batinic, D. / Durakovic, N. / Golubic-Cepulic, B. / Serventi-Seiwerth, R. / Radman, I. / Aurer, I. et al. | 2007
- S21
-
E11 Predicated health consequences of the Chernobyl nuclear power station accident 1986-2065Gale, R. P. et al. | 2007
- S21
-
Which myelodysplastic syndromes patients are candidates for transplantation?de Witte, T. / van Biezen, A. / Brand, R. / Suciu, S. / Kroger, N. et al. | 2007
- S22
-
E12 Therapy for T-cell non-Hodgkins lymphomaVose, J. M. / Neumann, M. / Harris, M. E. et al. | 2007
- S23
-
E13 Non-Hodgkin lymphoma: how to proceedAurer, I. et al. | 2007
- S25
-
E14 Therapy for CLL: current approach, future trendsKeating, M. J. et al. | 2007
- S27
-
E15 Therapy for chronic lymphocytic leukemia (CLL): how to proceedJaksic, B. et al. | 2007
- S31
-
OP02 Unrelated cord blood transplantation in children and adults with leukemias and lymphomasGluckman, E. / Ionescu, I. / Arrais, C. / Garnier, F. / Chevret, S. / Garcia, J. / Rocha, V. et al. | 2007
- S32
-
OP04 Safety and efficacy of the terminal complement inhibitor eculizumab in patients with paroxysmal nocturnal hemoglobinuria: Shepherd Phase III clinical study resultsMuus, P. / Luzzatto, L. / Rotoli, B. / Young, N. S. / Schubert, J. / Urbano-Ispizua, A. / Coyle, L. / DeCastro, C. / Fu, C. L. / Maciejewski, J. P. et al. | 2007
- S34
-
OP08 High dose (HD-AraC) vs standard dose cytosine arabinoside (SD-AraC) during induction in acute myelogenous leukemia (AML): Impact on stem cell mobilization after consolidation and on autologous transplantation (AML-12 trial)Willemze, R. / Suciu, S. / Mandelli, F. / de Witte, T. / Labar, B. / Marie, J. P. / Meloni, G. / Mistrik, M. / Liso, V. / Selleslag, D. et al. | 2007
- S35
-
OP10 AML in children: treatment approach in St. JudeBurnett, A. / Pui, C. H. / Rubnitz, J. / Ribeiro, R. / Leung, W. / Campana, D. et al. | 2007
- S36
-
OP11 AMLinolderpatients:theEORTC/GIMEMA experienceAmadori, S. / Stasi, R. et al. | 2007
- S37
-
OP12 Allogeneic stem cell transplantation for AML: does conditioning intensity matter?Blaise, D. et al. | 2007
- S38
-
OP13 Novel agents in acute myeloid leukemia (AML)Kantarjian, H. M. et al. | 2007
- S39
-
OP15 Front-line treatment of acute promyelocytic leukemia: the state of the artSanz, M. A. et al. | 2007
- S40
-
OP16 The role of arsenic trioxid in APL today, from expert consensus to European guidelinesLo Coco, F. et al. | 2007
- S41
-
OP18 Classifications of myelodysplastic syndromes (MDS): recent advancesGreenberg, P. L. et al. | 2007
- S42
-
OP21 Epigenetic therapy in the biological continuum of MDS and AMLLubbert, M. et al. | 2007
- S43
-
OP23 New therapeutics for myelodysplastic syndromes (MDS)List, A. F. et al. | 2007
- S44
-
OP25 Current therapy for ALL in adultsHoelzer, D. et al. | 2007
- S45
-
OP28 Novel agents for ALLOBrien, S. et al. | 2007
- S46
-
OP31 10-year results of the HD9 trial of the German Hodgkin Study Group comparing baseline and escalated BEACOPP chemotherapy for advanced Hodgkin lymphomaEngert, A. / Franklin, J. / Pfistner, B. / Diehl, V. et al. | 2007
- S47
-
OP33 Hodgkins lymphoma in CroatiaRadman, I. et al. | 2007
- S48
-
OP35 Modulation of immune responses by mesenchimal stem cellsFibbe, W. et al. | 2007
- S49
-
OP37 Direct intra-bone injection of unrelated cord blood cells overcomes the problem of delayed engraftment or failure to engraft and improves the feasibility of hematopoietic transplant in adult patientsRaiola, A. M. / Podesta, M. / Ibatici, A. / Gualandi, F. / Sessarego, N. / Parodi, A. / Pozzi, S. / Pinto, V. / Corselli, M. / Piaggio, G. et al. | 2007
- S50
-
OP39 Mechanisms of graft-versus-leukaemia reactions (GvL) in chimerasKolb, H. J. et al. | 2007
- S51
-
OP40 Techniques to optimize GvT/GvL effects and improve immune reconstitutionBarrett, J. et al. | 2007
- S53
-
OP45 Molecular pathogenesis and management of MPDsGreen, A. R. et al. | 2007
- S54
-
OP48 New therapeutic agents for myeloproliferative disordersVerstovsek, S. et al. | 2007
- S55
-
OP50 Bortezomib in the treatment of multiple myelomaBlade, J. et al. | 2007
- S56
-
OP51 The role of bisphosphonates in the management of myelomaBerenson, J. R. et al. | 2007
- S58
-
OP55 Management of relapsed indolent lymphomaCabanillas, F. et al. | 2007
- S59
-
OP57 Risk adapted treatment of young patients with DLBCLPfreundschuh, M. et al. | 2007
- S61
-
OP64 Therapeutic approaches in front-line therapy in chronic lymphocytic leukemiaRai, K. R. et al. | 2007
- S62
-
OP66 First line therapy with fludarabine, cyclophosphamide and rituximab for CLLKeating, M. J. et al. | 2007
- S63
-
OP68 Gene therapy for patients with CLLWierda, W. G. / OBrien, S. / Aguillon, R. A. / Castro, J. / McMannis, J. / Prussak, C. / Kipps, T. J. / Keating, M. J. et al. | 2007
- S65
-
P002 Microenvironment influence on cyclin A1 mRNA expression in AML blastsGolemovic, M. / Rnjak, L. / Sucic, M. / Mitrovic, Z. / Pisk-Mikulic, M. / Labar, B. / Batinic, D. et al. | 2007
- S66
-
P004 Changes in thymic recent output function in patients with acute myeloid leukemiaLi, Y. / Yin, Q. / Yang, L. / Chen, S. / Wu, X. / Schmidt, C. A. / Przybylski, G. et al. | 2007
- S67
-
P006 Burkitt lymphoma in adults: how to treat?Baryakh, E. / Valiev, T. / Kravchenko, S. / Kremenetskaya, A. / Magomedova, A. / Zvonkov, E. / Obukhova, T. / Vorobjev, A. et al. | 2007
- S69
-
P011 Pneumomediastinum complicating childhood non-Hodgkin lymphoma - case reportRoganovic, J. / Serventi-Seiwerth, R. / Mrsic, M. / Dobrota, S. / Cvitkovic, M. / Labar, B. et al. | 2007
- S70
-
P014 ARA-C and gemtuzumab ozogamicin (ARA-GO) is effective and safe therapy for elderly AML patientTothova, E. / Stecova, N. / Kafkova, A. / Guman, T. / Fricova, M. / Surova, M. / Svorcova, E. / Takac, V. et al. | 2007
- S71
-
P016 Granulocytic sarcoma: single institution expirienceAntic, D. / Tomin, D. / Cemerikic, V. / Perunicic, M. / Elezovic, I. / Suvajdzic, N. / Bakrac, M. / Bila, J. / Mitrovic, M. / Boskovic, D. et al. | 2007
- S72
-
P018 mTOR inhibitor rapamycin interacts synergistically with farnesyltransferase inhibitor FTI-277 to induce growth inhibition in human leukemia cellsMin, Y. H. / Eom, J. I. / Lee, H. W. / Kim, J. S. / Cheong, J. W. et al. | 2007
- S73
-
P020 Genetic and environmental determinants of plasma fibrinogen levels in geographically isolated populationPulanic, D. / Petrovecki, M. / Polasek, O. / Biloglav, Z. / Kolcic, I. / Rudan, I. et al. | 2007
- S75
-
P024 Inhibition of heat shock protein 90 prolongs survival of mice with BCR-ABL-T3151-induced leukemia suppresses leukemic stem cellsPeng, C. / Brian, J. / Hu, Y. / Goodrich, A. / Kong, L. / Grayzel, D. / Pak, R. / Read, M. / Reitsma, D. / Li, S. et al. | 2007
- S76
-
P027 A new international registry for patients with chronic myeloid leukemia: CAMELIAFaber, E. / Voglova, J. / Koza, V. / Kotoucek, P. / Demetrovicova, L. / Tothova, E. / Chudej, L. / Zak, P. / Jarosova, M. / Demeckova, E. et al. | 2007
- S77
-
P028 Monitoring CML patients responding to treatment with tyrosine kinase inhibitors with real-time quantitative polymerase chain reactionRadic Antolic, M. / Zadro, R. / Sertic, D. / Labar, B. et al. | 2007
- S78
-
P031 Imatinib and aging: preliminary evaluation of efficacy and toxicity of two CML groupsTothova, E. / Kafkova, A. / Surova, M. / Svorcova, E. et al. | 2007
- S81
-
P037 IgHV gene repertoire and HCDR3 region compositions in Ukrainian B-CLL patientsBilous, N. / Abramenko, I. / Chumak, A. / Kryachok, I. et al. | 2007
- S82
-
P040 Chronic natural killer cell lymphocytosisGrkovic, L. / Rnjak, L. / Sertic, D. / Serventi-Seiwerth, R. / Mikulic, M. / Dubravcic, K. / Batinic, D. / Labar, B. et al. | 2007
- S83
-
P042 Clinical stage-depending decrease of NK cell activity in multiple myeloma patientsJurisic, V. / Konjevic, G. / Mirjacic, K. / Markovic, O. / Colovic, M. et al. | 2007
- S84
-
P044 Efficacy of single-agent bortezomib and combination of bortezomib, melphalan, prednison in patients with relapsed and refractory multiple myeloma associated with poor clinical parametersGolenkov, A. / Mitina, T. / Lutskaya, T. / Chernykh, Y. / Kataeva, E. / Kedrov, A. / Inyutkina, N. / Vereschagina, V. / Fomin, A. / Koshelev, R. et al. | 2007
- S85
-
P047 The bi-specific T-cell enhancer (BiTE) MT103 (MEDI-538) shows clinical activity in pre-treated NHL: update from the ongoing Phase I study MT103-104Zugmaier, G. / Viardot, A. / Hess, G. / Noppeney, R. / Kufer, P. / Leo, E. / Reitsma, D. / Goebeler, M. / Knop, S. / Einsele, H. et al. | 2007
- S86
-
P049 Serum level of intercellular adhesion molecule-1 (ICAM-1) in patients with malignant lymphomaAbdelrazik, N. / Fouda, M. / Zaghloul, M. H. / Abbas, D. et al. | 2007
- S87
-
P051 Immunohistochemical expression patterns of germinal center and activation B-cell markers do not correlate with prognosis in diffuse large B-cell lymphoma treated with R-CHOPMitrovic, Z. / Aurer, I. / Nola, M. / Radman, I. / Basic-Kinda, S. / Ajdukovic, R. / Dominis, M. / Labar, B. et al. | 2007
- S88
-
P053 Prognostic and predictive significance of CD10 expression in diffuse large B cell lymphomaSofo Hafizovic, A. / Bijedic, V. / Dizdarevic, A. / Vila, M. / Kurtovic, S. / Medanhodzic, A. et al. | 2007
- S89
-
P056 International prognostic index, bulky disease, Ki67, bcl-2 and the outcome in newly diagnosed patients with diffuse large B cell lymphomaPerunicic Jovanovic, M. / Jakovic, L. / Mihaljevic, B. / Bogdanovic, A. / Andjelic, B. / Sretenovic, A. / Jankovic, S. / Boskovic, D. et al. | 2007
- S90
-
P058 Modified NHL-BFM-90 program in primary gastric diffuse large B-cell lymphoma (PGDLBCL) with adverse prognostic factorsZvonkov, E. / Baryakh, E. / Krasilnikova, B. / Magomedova, A. / Gubkin, A. / Kravchenko, S. / Kremenetskaya, A. / Vorobjev, A. et al. | 2007
- S93
-
P065 Survival benefits of patients with non-Hodgkins lymphoma treated with rituximab combined with chemotherapyKafkova, A. / Tothova, E. / Surova, M. et al. | 2007
- S94
-
P067 FMC/FMC-R regiments efficiency in treatment of primary ocular adnexal MALT-lymphomasKrasilnikova, B. / Zvonkov, E. / Kravchenko, S. / Grishina, E. / Kremenetskaya, A. / Vorobjev, A. et al. | 2007
- S95
-
P070 Primary diffuse large B-cell lymphoma of the spleenMagomedova, A. / Kravchenko, S. / Kremenetskaya, A. / Zvonkov, E. / Zibunova, E. E. et al. | 2007
- S98
-
P077 The abeyance or initial drastic tratment in mycosis fungoides variantsGaman, G. / Gaman, A. et al. | 2007
- S100
-
P082 Enhancement of immune and hematopoietic reconstitution by IL-7 following experimental bone marrow transplantation in a murine model may be mediated by IL-2 and RAG-1 activationAbdul-Hai, A. / Ben-Yehuda, A. / Friedman, G. / Ergaz, D. et al. | 2007
- S101
-
P084 Excellent anti-leukaemic efficacy of allogeneic-SCT after FLAMSA chemotherapy and reduced intensity conditioning in patients with high risk myeloid malignancies aged 60 years or olderSchleuning, M. / Judith, D. / Kaltenhauser, J. / Burlakova, I. / Taube, R. / Bertelsmann, A. / Baurmann, H. / Schwerdtfeger, R. et al. | 2007
- S102
-
P086 Allogeneic stem cell transplantation for advanced cutaneous T-cell lymphopma: unicentric experiencePostorino, M. / Cantonetti, M. / Franceschini, L. / De Angelis, G. / Cudillo, L. / Cerretti, R. / Gianni, L. / Rizzo, M. / Lombardo, G. / Didona, B. et al. | 2007
- S103
-
P088 PCR-STR method in monitoring chimerism status after hematopoietic stem cell transplantationGrubic, Z. / Stingl, K. / Cecuk-Jelicic, E. / Zunec, R. / Serventi-Seiwerth, R. / Rajic, L. / Labar, B. / Brkljacic-Kerhin, V. et al. | 2007
- S104
-
P090 Molecular detection of Epstein-Barr virus in patients with bone marrow transplantationVince, A. / Zidovec-Lepej, S. / Kozic, S. / Baca-Vrakela, I. / Serventi-Seiwerth, R. / Grkovic, L. / Labar, B. et al. | 2007
- S105
-
P092 Acute myelomonocytic leukemia after HSCT with reduced intensity conditioning for CLL: a case reportServenti-Seiwerth, R. / Mrsic, M. / Aurer, I. / Nemet, D. / Radman, I. / Dubravcic, K. / Sucic, M. / Sertic, D. / Batinic, D. / Bojanic, I. et al. | 2007
- S106
-
P095 Long term follow up of autologous transplant in AML patients in first complete remissionCevreska, L. / Pivkova, A. / Genadieva Stavrik, S. / Stojanoski, Z. / Krstevska Balkanov, S. / Trajkova, S. / Georgievski, B. et al. | 2007
- S107
-
P097 Toxicity related to autologous peripheral blood hematopoietic progenitor cell infusion is associated with number of granulocytes in graft, gender and diagnosis of multiple myelomaBojanic, I. / Golubic-Cepulic, B. / Mazic, S. / Lukic, M. / Plenkovic, F. / Dubravcic, K. / Batinic, D. / Serventi-Seiwerth, R. / Sertic, D. / Mrsic, M. et al. | 2007
- S108
-
P099 Efficacy and safety of colistin for the treatment of infections caused by multidrug-resistant isolates of Pseudomonas aeruginosa sensitive to colistin in patients with haematological malignancyDurakovic, N. / Boban, A. / Mrsic, M. / Sertic, D. / Serventi-Seiwerth, R. / Nemet, D. / Labar, B. et al. | 2007
- S109
-
P100 Predictors of outcome for patients with haematological malignancies in ICUGasparovic, V. / Gornik, I. / Orsulic, A. / Ilic, M. et al. | 2007
- S110
-
P102 Bone marrow trabnsplantation for acute myeloid leukemia from donor with Gaucher disease followed by enzyme replacement therapy (ERT)Mrsic, M. / Labar, B. / Serventi-Seiwerth, R. / Potocki, K. / Fumic, K. / Stern-Padovan, R. / Prutki, M. / Durakovic, N. / Bogdanic, V. et al. | 2007
- S112
-
S02 Molecular monitoring and ELN guidelines for CMLGoldman, J. et al. | 2007
- S114
-
S04 Mechanisms of transfusional iron overload toxicity and monitoring of iron overloadPorter, J. et al. | 2007
- S117
-
Author Index| 2007
- S144
-
PO033 Results of the treatment with erythropoietin in myelodysplastic syndrome in 25 patients from a single Romanian centerTatic, A. / Ursuleac, I. / Puscariu, T. / Gologan, R. / Colita, A. / Colita, D. et al. | 2007
-
Editorial Board| 2007
-
OP06 Gene-expression micro-array in AML diagnosticsLowenberg, B. et al. | 2007
-
OP27 More intensive chemotherapy for young adults with ALL?Marrie, J. P. / Haiat, S. / Legrand, O. et al. | 2007
-
OP59 Radioimmunotherapy for treatment of non-Hodgkin lymphomaZinzani, P. L. et al. | 2007
-
P003 CD11a, myeloperoxidase and alkaline phosphatase expression in bone marrow mature granulopoietic cells in patients with AML and ALLSucic, M. / Marosevic, L. / Simonovic, B. / Markovic-Glamocak, M. / Ries, S. / Gjadrov-Kuvezdic, K. / Nemet, D. / Mikulic, M. / Labar, B. et al. | 2007
-
P033 The JAK kinase inhibitor CP-690,550 supresses the growth of human polycythemia vera cells carrying the JAK2V617F mutationManshouri, T. / Quintas-Cardama, A. / Nussenzveig, R. H. / Gaikwad, A. / Estrov, Z. / Cortes, J. / Kantarjian, H. M. / Verstovsek, S. et al. | 2007
-
P059 Long-term results of CHOP/CHOP like chemotherapy +- rituximab in patients with diffuse large B-cell lymphoma (DLBCL)Mihaljevic, B. / Sretenovic, S. / Jankovic, S. / Andjelic, B. / Jakovic, L. / Milicic, B. / Bila, J. / Milosevic, V. / Sretenovic, A. / Perunicic, M. et al. | 2007
-
P060 The influence of international prognostic score and bulky disease in patients with primary mediastinal B sclerosing lymphoma treated with immunochemotherapyMihaljevic, B. / Andjelic, B. / Jakovic, L. / Jankovic, S. / Sretenovic, A. / Bila, J. / Mitrovic, M. / Milosevic, V. / Perunicic, M. / Solujic, S. et al. | 2007
-
P064 Treatment of pediatric diffuse large B-cell non-Hodgkins lymphomas with intensive chemotherapy + rituximab: preliminary resultsSamochatova, E. / Shelikhova, L. / Myakova, N. / Fechina, L. / Khlebnikova, O. / Belogurova, M. / Varfolomeeva, S. / Litvinov, D. / Shamardina, A. / Basharova, E. et al. | 2007
-
P066 The combination of rituximab and HyperCVAD in treatment of Burkitt lymphoma - a single institution expirienceJankovic, S. / Mihaljevic, B. / Andjelic, B. / Jakovic, L. / Milosevic, V. / Todorovic, M. / Mitrovic, M. / Colovic, M. / Sretenovic, A. / Perunicic, M. et al. | 2007
-
P071 ABVP protocol for primary treatment of advanced adult Hodgkin disease: the Casablanca experienceQachouh, M. / Quessar, A. / Benchekroun, S. et al. | 2007
-
P072 Prognostic role of FDG-PET in clinical management of Hodgkin lymphoma patients with residual mass - long term follow-upMarton, I. / Molnar, Z. / Borbenyi, Z. / Galuska, L. / Keresztes, K. / Rosta, A. / Simon, Z. / Illes, A. / Tron, L. / Papos, M. et al. | 2007
-
P081 Spontaneous splenic rupture in two patients with hematologic malignancySzotkowski, T. / Szotkowska, R. / Pikalova, Z. / Tichy, T. / Flodr, P. / Tichy, M. / Houserkova, D. / Benysek, V. / Zlamalova, N. / Ruzicka, V. et al. | 2007
-
P087 Final height of children after stem cell transplanKook, H. / Park, E. Y. / Baek, H. J. / Han, D. K. / Kim, C. J. / Woo, Y. J. / Kim, H. J. / Hwang, T. J. et al. | 2007
-
Animal models of myelodysplasia: BCL-2 and mutant NRAS-mediated disease progressionPadua, R. A. et al. | 2007
-
The immune pathophysiology of bone marrow failure and the emergence of clonal hematologic diseasesYoung, N. S. / Barrett, A. J. / Sloand, E. M. et al. | 2007
-
Genetics of chronic myeloproliferative disordersSkoda, R. et al. | 2007
-
Acute myeloid leukaemia carrying cytoplasmic mutated nucleophosmin (NPMc+ AML): molecular and clinico-pathological featuresFalini, B. / Nicoletti, I. / Martelli, M. F. / Mecucci, C. et al. | 2007
-
C023 Expression profiling of CD34+ cells in patients with myelodysplastic syndromes: differences between early and advanced cases and analysis of apoptosis-related genesPellagatti, A. / Cazzola, M. / Giagounidis, A. / Malcovati, L. / Porta, M. G. D. / Jadersten, M. / Killick, S. / Fidler, C. / Cattan, H. / Bowen, D. et al. | 2007
-
P009 Genetic polymorphisms of DNA-repair- and detoxification enzymes in therapy-related AML and MDSFischer, S. / Seedhouse, C. / Schulz, T. / Westphal, G. / Haase, D. et al. | 2007
-
P028 High levels of telomerase activity in myelodysplastic syndromes are associated with eroded telomeres and shorter survivalZizkova, H. / Cermak, J. / Vcelikova, S. / Neuwirtova, R. / Michalova, K. / Sieglova, Z. et al. | 2007
-
P056 Is the increased apoptosis a cause of impaired CD34+ B-cell precursors production in myelodysplastic syndromes?Sandes, A. F. / Kimura, E. Y. S. / Silva, M. C. A. / Barroso, R. S. / Chauffaille, M. L. L. F. / Pinheiro, R. F. / Yamamoto, M. et al. | 2007
-
P070 Whole genome association study in leukemia: frequent loss of heterozygosity in acute myeloid leukemia with a normal karyotypeCha, Y. / Ahn, K.-S. / Park, J. / Kim, B.-S. / Bang, S.-M. / Kim, I.-H. / Yoon, S.-S. / Lee, D. / Lee, Y. Y. / Park, S. et al. | 2007
-
P071 Endoplasmic reticulum gene expression profile of erythroid progenitors in low risk myelodysplastic syndromesGyan, E. / Sternberg, A. / Leclercq-Cardus, S. / Willems, L. / Cagnard, N. / Frisan, E. / Dreyfus, F. / Lacombe, C. / Vyas, P. / Fontenay, M. et al. | 2007
-
P081 Assessment of myelodysplasia in MDS and secondary leukemia. Application of a scoring table to the WHO classificationAndrieu, V. / Duchayne, E. / Grange, M. J. / Guesnu, M. / Imbert, M. / Picard, F. / Groupe Francais des Myelodysplasies et al. | 2007
-
P089 Biological significance of CD7-positive blasts in myelodysplastic syndromesSato, C. / Tamura, H. / Yamashita, T. / Tsuji, T. / Dan, K. / Ogata, K. et al. | 2007
-
P104 Prognostic role of transfusion requirement in myelodysplastic syndromesSalvi, F. / Gioia, D. / Cilloni, D. / Audisio, E. / Boccomini, C. / Bonferroni, M. / Cametti, G. / Ciravegna, G. / Darbesio, A. / Dellacasa, C. et al. | 2007
-
P117 Prevalence of cardiac disease among a US medicare population with myelodysplastic syndromesGoldberg, S. L. / Mody-Patel, N. / Warnock, N. et al. | 2007
-
P128 Retrospective survey highlights the iron burden in Japanese transfusion-dependent patients with MDSTakatoku, M. / Uchiyama, T. / Okamoto, S. / Kanakura, Y. / Sawada, K. / Tomonaga, M. / Nakao, S. / Nakahata, T. / Harada, M. / Murate, T. et al. | 2007
-
P130 The importance of iron stores in the chelation treatment of patients with myelodysplastic syndromesNielsen, P. / Bruemmendorf, T. H. / Kroger, N. / Grosse, R. / Engelhardt, R. / Leismann, O. / Fischer, R. / Zander, A. R. et al. | 2007
-
P137 Response to erythropoietin (EPO) with or without differentiating treatment with 13-cis-retinoic-acid and dihydroxylated vitamin D3 in myelodysplastic syndromes (MDS)Ferrero, D. / Gioia, D. / Cilloni, D. / Audisio, E. / Cametti, G. / Darbesio, A. / Dellacasa, C. / Lunghi, M. / Gaidano, G. / Girotto, M. et al. | 2007
-
P143 Combination of erythropoietin and low-dose thalidomide for the management of anemia of low-grade myelodysplasiaLeb, L. / Khanani, S. / Rooney, J. / Seidler, C. et al. | 2007
-
P153 Clinical effects of 5-azacitidine five days/monthly schedule in three symptomatic low-risk (IPSS: 0-1) myelodysplastic patientsFili, C. / Bergonzi, C. / Skert, C. / Malagola, M. / Roccaro, A. M. / Peli, A. / Capuzzi, E. / Russo, D. et al. | 2007
-
PO016 Secondary leukemia in a patient with multiple myeloma treated by a standard protocol of chemotherapy and autologous bone marrow transplantationLorand-Metze, I. / Kameo, R. E. / Oliveira-Duarte, G. / Fattori, A. / Aranha, F. P. / Vigorito, A. C. / de Souza, C. A. et al. | 2007
-
PO028 Clinical and cytogenetic features of the secondary leukemias, induced by preceding antitumor treatmentVygovska, J. / Lukavetsky, L. / Serafyn, N. / Kotlyarchuk, K. / Mazurok, A. / Tsiapka, O. / Masliak, Z. et al. | 2007
-
Which myelodysplastic syndromes patients are candidates for treatment with hematopoietic growth factors?Fenaux, P. et al. | 2007
-
Do histone deacetylase inhibitors have a place in the treatment of myelodysplastic syndromes?Gore, S. D. et al. | 2007
-
C019 Genome-wide analysis of copy number change and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density SNP arraysWang, L. / Fidler, C. / Giagounidis, A. / Cazzola, M. / Malcovati, L. / Killick, S. / Aul, C. / Boultwood, J. / Wainscoat, J. S. et al. | 2007
-
P064 Downregulation of microsomal carnitine palmitoyltransferase (mCPT) in myelodysplastic syndromes (MDS) - induced by hypermethylation and/or reduced carnitine availabilityPfeilstocker, M. / Karlic, H. / Wihlidal, P. / Nosslinger, T. / Pittermann, E. et al. | 2007
-
P073 Gene expression profiling in the myelodysplastic syndrome: patients with intermediate 1 versus higher riskKracmarova, A. / Bruchova, H. / Belickova, M. / van Delft, J. / Cermak, J. / Brdicka, R. et al. | 2007
-
P085 Morphologic differential diagnosis of juvenile myelomonocytic leukemia (JMML)Karow, A. / Niemeyer, C. M. et al. | 2007
-
P086 Flow cytometry in myelodysplastic syndromes: a new tool in the classification and prognostification of low/int-I risk MDSvan de Loosdrecht, A. A. / Westers, T. M. / Westra, A. H. / Drager, A. M. / van der Velden, V. H. J. / Ossenkoppele, G. J. et al. | 2007
-
P091 B7-H1 molecules on blasts in myelodysplastic syndromesKondo, A. / Yamashita, T. / Tamura, H. / Sato, C. / Jo, R. / Tsuji, T. / Dan, K. / Ogata, K. et al. | 2007
-
P140 Factors predicting for a favorable response among patients with myelodysplastic syndromes treated with erythropoietin +/- G-CSFSymeonidis, A. / Kouraklis-Symeonidis, A. / Zikos, P. / Galanopoulos, A. / Psyllaki, M. / Aktypi, A. / Michalopoulou, S. / Michali, E. / Protopapa, M. / Pantelidou, D. et al. | 2007
-
P145 A meta-analysis of the published studies and the long-term results of a large personal experience form the basis for an appropriate use of thalidomide in myelodysplastic syndromesMusto, P. et al. | 2007
-
P144 Thalidomide alone or in combination with other agents for the treatment of myelodysplastic syndromes (MDS)Candoni, A. / Raza, A. / Galili, N. / Simeone, E. / Buttignol, S. / Silvestri, F. / Fanin, R. et al. | 2007
-
PO011 Modelling the cost-effectiveness of Deferasirox (Exjade) in the treatment of iron overloaded myelodysplastic syndrome patientsKarnon, J. / Baladi, J. F. et al. | 2007
-
PO024 Association of V617F JAK2 mutation and myelodysplastic 5q- syndrome without anemiaEspanel, C. / Herault, O. / Kafando, E. / Bacq, Y. / Barin, C. / Petit, A. / Binet, C. / Domenech, J. et al. | 2007
-
OP01 Treatment of acute leukemia: 50 years laterFreireich, E. et al. | 2007
-
OP07 3&7 remains the standard induction therapy for AMLSchiffer, C. A. et al. | 2007
-
OP14 Design and analysis of clinical trials in acute leukemia: review of a 25-year experienceSuciu, S. et al. | 2007
-
OP20 Low-risk MDS - do we need more than suportive care?Hellstrom-Lindberg, E. et al. | 2007
-
OP22 Stem cell transplantation (SCT) for MDSde Witte, T. et al. | 2007
-
OP53 Autologous versus allogenic stem cell transplantation for multiple myelomaAttal, M. et al. | 2007
-
P012 Epidemiological features of leukaemias in Federation of Bosnia and Herzegovina from 1992 to 2000Bijedic, V. / Klanancevic, L. / Kurtovic, S. / Medanhodzic, A. / Sofo-Hafizovic, A. / Dizdarevic, A. / Vila, M. et al. | 2007
-
P017 Acute promyelocytic leukemia in an HIV-infected patient - a case reportBoban, A. / Radman, I. / Lisic, M. / Maretic, T. / Civljak, R. / Zadro, R. / Begovac, J. et al. | 2007
-
P041 Molecular detection and clinics of IgH/MMSET of t(4;14)(4p16;14q32) in multiple myelomaKusec, R. / Livun, A. / Marusic Vrsalovic, M. / Ostojic Kolonic, S. / Haris, V. / Ajdukovic, R. / Jaksic, O. / Pejsa, V. et al. | 2007
-
P073 Analysis of B-cell clonality in composite Hodgkin disease and non-Hodgkins lymphomaAntic, D. / Cikota, B. / Cemerikic, V. / Tomin, D. / Jankovic, G. / Vidovic, A. / Djunic, I. / Petrovic, M. / Mihaljevic, B. / Nedeljkov Jancic, R. et al. | 2007
-
P096 After the 100th autologous peripheral haemopoietic stem cell transplantation in the 2nd Department of the Medicine, University of Debrecen, HungaryKiss, A. / Remenyi, G. / Szasz, R. / Batar, P. / Fazekas, G. / Sipos, T. / Kovacs, E. / Szarvas, M. / Udvardy, M. et al. | 2007
-
OP62 The value of FDG/PET in non-Hodgkins lymphoma managementTrneni, M. et al. | 2007
-
P001 Acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma and non-Hodgkins lymphoma carrying mutated CCAAT/enhancer-binding protein alphaFuchs, O. / Provaznikova, D. / Kocova, M. / Kostecka, A. / Neuwirtova, R. / Kobylka, P. / Cermak, J. / Brezinova, J. / Schwarz, J. / Salaj, P. et al. | 2007
-
P008 Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: a randomized case-controlled studyAbdelrazik, N. / Fouda, M. et al. | 2007
-
P055 Clinical and morphological characteristics of non-Hodgkins lymphomasBabkina, A. V. / Toloknov, B. O. / Poddubnaya, I. et al. | 2007
-
S03 Novel TKI therapies for CML: targeting Bcr-Abl with TasignaTalpaz, M. et al. | 2007
-
Molecular analysis of the 5q- syndromeBoultwood, J. et al. | 2007
-
Treating non-del 5q patients with lenalidomideSchiffer, C. A. et al. | 2007
-
Improved survival in myelodysplastic syndromes patients receiving iron chelation therapyLeitch, H. A. et al. | 2007
-
Guidelines on iron chelation therapy in patients with myelodysplastic syndrome and transfusion iron overloadGattermann, N. et al. | 2007
-
Is traditional low dose chemotherapy (cytarabine/melphalan) still an option?Bowen, D. et al. | 2007
-
C012 Prevalence and prognostic significance of allelic imbalance by single nucleotide polymorphism analysis in low risk myelodysplastic syndromesMohamedali, A. / Gaken, J. / Twine, N. / Ingram, W. / Westwood, N. / Lea, N. / Hayden, J. / Carlo, A. / Gattermann, N. / Giagounidis, A. et al. | 2007
-
C021 SNP-array karyotyping complements routine metaphase cytogenetics in the detection of chromosomal aberrations including uniparental disomy in MDSTiu, R. V. / Gondek, L. P. / Haddad, A. / O Keefe, C. L. / Sekeres, M. A. / Yamamoto, G. / Ogawa, S. / Maciejewski, J. P. et al. | 2007
-
P001 Incidence of myelodysplastic syndromes in the United States medicare populationGoldberg, S. L. / Mody-Patel, N. / Warnock, N. et al. | 2007
-
P010 Incidence and risk factors of secondary myelodysplastic syndrome/acute leukemia occurrence following peripheral blood progenitor cell autograft: a GITIL (Gruppo Italiano Terapie Innovative Nei Linfomi) survey on 1266 lymphoma patientsZanni, M. / Magni, M. / Rambaldi, A. / Benedetti, F. / Rosato, R. / Passera, R. / Patti, K. / Ciceri, F. / Gallamini, A. / Cortelazzo, S. et al. | 2007
-
P015 Clinical and prognostic features of patients with myelodysplastic/myeloproliferative syndrome categorised as unclassified (MDS/MPD-U) by WHO classificationBreccia, M. / Gentilini, F. / Stefanizzi, C. / Levi, A. / Natalino, F. / Latagliata, R. / Nanni, M. / Alimena, G. et al. | 2007
-
P026 Different pattern of JNK activity in MDS-related versus de novo AML: implications for apoptosis-resistance and treatment failure in MDS-related AMLLagadinou, E. D. / Ziros, P. / Tsopra, O. / Klamargias, A. / Thanopoulou, E. / Kouraklis, A. / Spyridonidis, A. / Karakantza, M. / Zoumbos, N. C. et al. | 2007
-
P054 Anti-erythroblast autoimmunity in early MDSZaninoni, A. / Imperiali, F. G. / Colombi, M. / Barcellini, W. et al. | 2007
-
P069 Genome-wide DNA-mapping of CD34+ cells from MDS patients with 500K SNP arrays identifies significant regions of genomic alterationsNowak, D. / Wagner, F. / Nolte, F. / Baldus, C. C. / Hopfer, O. / Mossner, M. / Serbent, V. / Thiel, E. / Hofmann, W. K. et al. | 2007
-
P080 Morphological features and prognostic implication in a retrospective analysis of 370 patients with myelodysplastic syndromeBenatti, C. / Travaglino, E. / Ascari, E. / Guglielmana, B. K. / Malcovati, L. / Porta, M. G. D. / Invernizzi, R. et al. | 2007
-
P108 The joint impact of cytogenetics, together with age, gender and classification on survival in MDSMakrai, A. / Tuchler, H. / Nosslinger, T. / Pittermann, E. / Pfeilstocker, M. et al. | 2007
-
P111 Analysis of modified WHO classification-based prognostic scoring system (WPSS) for Japanese MDS patientsAraseki, K. / Matsuda, A. / Jinnai, I. / Ishikawa, M. / Yagasaki, F. / Iwanaga, M. / Bessho, M. / Tomonaga, M. et al. | 2007
-
P125 Pregnancy in patients with myelodysplastic syndromes (MDS)Volpicelli, P. / Latagliata, R. / Breccia, M. / Carmosino, I. / Stefanizzi, C. / Iannella, E. / Levi, A. / Natalino, F. / Alimena, G. et al. | 2007
-
P133 Patients with myelodysplastic syndromes (MDS) challenge transfusion resources now and in the futurePlesnila-Frank, C. / Berger, K. / Vioni-Niemeyer, A. / Schramm, W. et al. | 2007
-
P156 Allogeneic stem cell transplantation in patients with poor prognosis myelodysplastic syndrome (MDS) or secondary acute myeloid leukaemia (sAML): results from a single centre experienceTassara, M. / Crotta, A. / Peccatori, J. / Assanelli, A. / Corti, C. / Guggiari, E. / Stanghellini, M. T. L. / Servida, P. / Ruggeri, A. / Calbi, V. et al. | 2007
-
PO002 The clinical, hematological and morphological profile of patients with myelodysplastic syndromes: a single institution experience from TurkeyDemirkan, F. / Alacacioglu, I. / Ozsan, G. H. / Piskin, O. / Akinci, B. / Ozcan, M. A. / Yavuzsen, T. / Yuksel, E. / Undar, B. et al. | 2007
-
PO006 The impact of phenotypic abnormalities on survival of myelodysplastic syndromesLorand-Metze, I. / Califani, S. M. V. / Ribeiro, E. / Lima, C. S. P. / Saad, S. T. O. / Metze, K. et al. | 2007
-
PO015 Therapy-related MDS/AML after autologous stem transplantation for lymphoma with BEAM as conditioning: our experienceBelohlavkova, P. / Zavrelova, A. / Zak, P. / Cermanova, M. / Belada, D. / Voglova, J. / Jebavy, L. / Maly, J. et al. | 2007
-
PO019 Acute myelogenous leukemia (AML) type induction chemotherapy for the patients with myelodysplastic syndrome (MDS)Kim, D.-Y. / Kim, J.-S. / Kim, B.-S. / Bang, S.-M. / Kim, I. / Yoon, S.-S. / Park, S. / Kim, B. K. et al. | 2007
-
PO032 Epidemiology and classification of MDS: 74 casesBedoui, M. / Abid, H. B. / Zahra, K. / Zarrouk, M. / Jeddi, R. / Aissaoui, L. / Lakhal, R. / Amor, R. B. / Haj, Z. B. / Meddeb, B. et al. | 2007
-
Epidemiologic features in myelodysplastic syndromesGerming, U. / Strupp, C. / Aul, C. et al. | 2007
-
Combination epigenetic therapyGarcia-Manero, G. et al. | 2007
-
WPSS, a dynamic prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromesMalcovati, L. et al. | 2007
-
Immunophenotypic analysis of myelodysplastic syndromesPorta, M. G. D. et al. | 2007
-
Increased apoptosis as a mechanism of ineffective erythropoiesis in myelodysplastic syndromesInvernizzi, R. / Travaglino, E. et al. | 2007
-
C008 Clinical and molecular features in patients with juvenile myelomonocytic leukemia-like myeloproliferative disease and Noonan syndromeKratz, C. P. / Niemeyer, C. M. et al. | 2007
-
C013 The influence of therapeutic strategies on survival in distinct cytogenetic subgroups - A collaborative study based on 3860 patients with MDSSchanz, J. / Germing, U. / Steidl, C. / Pfeilstocker, M. / Nosslinger, T. / Hildebrandt, B. / Kundgen, A. / Lubbert, M. / Kunzmann, R. / Giagounidis, A. et al. | 2007
-
C016 A previous diagnosis of myelodysplastic syndrome has no influence on the clinical outcome of elderly patients with acute myeloid leukaemiaFerrara, F. / Palmieri, S. / Viola, A. / Annunziata, M. / D Amico, M. R. / Tambaro, F. P. / Mele, G. et al. | 2007
-
C025 Low IPSS score and bone marrow hypocellularity in MDS patients predict haematological responses to anti-thymocyte globulinLim, Z. Y. / Killick, S. / Germing, U. / Cavenagh, J. / Culligan, D. / Bacigalupo, A. / Marsh, J. / Mufti, G. J. et al. | 2007
-
C028 Cytogenetic response to lenalidomide is associated with improved survival in patients with chromosome 5q deletionList, A. F. / Wride, K. / Dewald, G. W. / Bennett, J. M. / Giagounidis, A. / Kurtin, S. / Knight, R. D. et al. | 2007
-
C032 Allogeneic hemopoietic stem cell transplantation for patients with myelodysplastic syndrome: the effect of blast count and disease status at transplantBacigalupo, A. / Lamparelli, T. / Gualandi, F. / Occhini, D. / Bregante, S. / Raiola, A. M. / Ibatici, A. / di Grazia, C. / Dominietto, A. / Bruno, B. et al. | 2007
-
C031 Allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndromes 50 years or older. A retrospective survey from the European Group for Blood and Marrow TransplantationLim, Z. Y. / Brand, R. / Martino, R. / Iacobelli, S. / Jansen, T. / van Biezen, A. / Finke, J. / Bacigalupo, A. / Beelen, D. / Reiffers, J. et al. | 2007
-
P006 Idiopathic cytopenia of uncertain significance (ICUS) versus low risk MDS: the diagnostic interfaceValent, P. / Wimazal, F. / Fonatsch, C. / Thalhammer, R. / Schwarzinger, I. / Mullauer, L. / Sperr, W. R. / Bennett, J. M. et al. | 2007
-
P014 Chromosomal pattern study in hypocellular primary myelodysplastic syndrome and its correlation with clinical and cellular aspectsde Souza, D. C. / Camargo, A. / Rodrigues, E. F. / Otero, L. / de Cassia Tavares, R. / Dobbin, J. / Bouzas, L. F. / Ornellas, M. H. / de Souza Fernandez, T. et al. | 2007
-
P018 Correlation between microvessel density (MVD) and vascular endothelial growth factor (VEGF) expression in myelodysplatic syndromes (MDS)Fracchiolla, N. S. / Gianelli, U. / Vener, C. / De Cavilli, E. / Pasquini, M. C. / Colombi, M. A. / Bosari, S. / Cortelezzi, A. / Deliliers, G. L. et al. | 2007
-
P019 TNF-alpha and VEGF serum levels in patients with different subtypes of MDSSerafyn, N. / Vyhovska, J. / Danysh, O. / Tomashevska, N. / Masliak, Z. et al. | 2007
-
P022 Impaired clonogenic and proliferative potential of bone marrow mesenchymal stem cells in patients with myelodysplastic syndromesStavroulaki, E. / Klaus, M. / Kastrinaki, M.-C. / Kalpadaki, C. / Gvazava, G. / Ximeri, M. / Psyllaki, M. / Galanopoulos, A. / Viniou, A.-N. / Parcharidou, A. et al. | 2007
-
P024 PKCζ involvement in the impaired SDF1alpha-mediated migration of marrow CD34^+ cells from MDS patientsThanopoulou, E. / Pherson, L. / Grigorakaki, T. / Tsopra, O. / Lagadinou, E. / Zoumbos, N. et al. | 2007
-
P035 Significance of bone marrow storage iron in patients with myelodysplastic syndromesWong, L. / Go, L. / Koss, W. / Wajima, T. et al. | 2007
-
P036 The oral iron chelator ICL670 is a potent inhibitor of NF-kB and this activity is independent from iron overload in MDS cellsCilloni, D. / Rosso, V. / Messa, E. / Messa, F. / Arruga, F. / Defilippi, I. / Catalano, R. / Carturan, S. / Bittoto, C. / Boveri, C. et al. | 2007
-
P052 Detection of humoral immune responses against Wilms tumor gene (WT1) product in patients affected by myelodysplastic syndromesCilloni, D. / Nicoli, P. / Defilippi, I. / Girola, E. / Bondi, A. / Messa, E. / Roetto, A. / Messa, F. / Arruga, F. / Carturan, S. et al. | 2007